{
  "name": "Federal controlled substance schedule (I-V) by drug, with DEA code number",
  "description": "Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.",
  "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/",
  "licence": "Federal regulatory text (21 CFR), not copyrightable",
  "last_verified": "2026-09-01",
  "stale_after": "2026-12-30",
  "sources": [
    "https://www.ecfr.gov/current/title-21/chapter-II/part-1308"
  ],
  "records": [
    {
      "substance_name": "1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9097",
      "temporary_expiry": "Aug. 27, 2028",
      "citation": "21 CFR 1308.11(h)(92)",
      "id": "1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | 9097 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-[1-(2-thienyl)cyclohexyl]pyrrolidine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7473",
      "citation": "21 CFR 1308.11(d)(35)",
      "id": "1-1-2-thienyl-cyclohexyl-pyrrolidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-2-thienyl-cyclohexyl-pyrrolidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7552",
      "citation": "21 CFR 1308.11(d)(105)",
      "id": "1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | 7552 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7549",
      "citation": "21 CFR 1308.11(d)(101)",
      "id": "1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | 7549 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7547",
      "citation": "21 CFR 1308.11(d)(80)",
      "id": "1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | 7547 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7541",
      "citation": "21 CFR 1308.11(d)(62)",
      "id": "1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7542",
      "citation": "21 CFR 1308.11(d)(64)",
      "id": "1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7089",
      "citation": "21 CFR 1308.11(d)(83)",
      "id": "1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(83) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | 7089 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7014",
      "citation": "21 CFR 1308.11(d)(93)",
      "id": "1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(93) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | 7014 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1245",
      "citation": "21 CFR 1308.11(d)(88)",
      "id": "1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(88) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | (1245) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7011",
      "citation": "21 CFR 1308.11(d)(49)",
      "id": "1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(49) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | (7011) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7201",
      "citation": "21 CFR 1308.11(d)(108)",
      "id": "1-5-fluoropentyl-3-1-naphthoyl-indole-am2201",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-3-1-naphthoyl-indole-am2201/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7083",
      "citation": "21 CFR 1308.11(d)(92)",
      "id": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(92) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | 7083 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7085",
      "citation": "21 CFR 1308.11(d)(85)",
      "id": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(85) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | 7085 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(3)",
      "id": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenediol-3-17-dihydroxy-5-androst-1-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) 1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(4)",
      "id": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) 1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-androstenedione (5\u03b1-androst-1-en-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(7)",
      "id": "1-androstenedione-5-androst-1-en-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenedione-5-androst-1-en-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) 1-androstenedione (5\u03b1-androst-1-en-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1258",
      "citation": "21 CFR 1308.11(d)(67)",
      "id": "1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7118",
      "citation": "21 CFR 1308.11(d)(107)",
      "id": "1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-phenylcyclohexylamine",
      "schedule": "Schedule II",
      "category": "Immediate precursors",
      "dea_code_number": "7460",
      "citation": "21 CFR 1308.12(g)(2)(i)",
      "id": "1-phenylcyclohexylamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-phenylcyclohexylamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) 1-phenylcyclohexylamine | 7460 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "1-piperidinocyclohexanecarbonitrile (PCC)",
      "schedule": "Schedule II",
      "category": "Immediate precursors",
      "dea_code_number": "8603",
      "citation": "21 CFR 1308.12(g)(2)(ii)",
      "id": "1-piperidinocyclohexanecarbonitrile-pcc",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-piperidinocyclohexanecarbonitrile-pcc/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(ii) 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9770",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(79)",
      "id": "2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(79) 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | 9770 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9765",
      "citation": "21 CFR 1308.11(b)(42)",
      "id": "2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(42) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | 9765 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9767",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(81)",
      "id": "2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(81) 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | 9767 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9768",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(82)",
      "id": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(82) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | 9768 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9771",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(84)",
      "id": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(84) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | 9771 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7509",
      "citation": "21 CFR 1308.11(d)(38)",
      "id": "2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7508",
      "citation": "21 CFR 1308.11(d)(39)",
      "id": "2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7524",
      "citation": "21 CFR 1308.11(d)(46)",
      "id": "2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7521",
      "citation": "21 CFR 1308.11(d)(45)",
      "id": "2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7517",
      "citation": "21 CFR 1308.11(d)(44)",
      "id": "2-2-5-dimethoxyphenyl-ethanamine-2c-h",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxyphenyl-ethanamine-2c-h/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9766",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(80)",
      "id": "2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(80) 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene) | 9766 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(29)",
      "id": "2-3-epithio-17-methyl-5-androstan-17-ol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-3-epithio-17-methyl-5-androstan-17-ol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(29) 2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7536",
      "citation": "21 CFR 1308.11(d)(57)",
      "id": "2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | (7536) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7519",
      "citation": "21 CFR 1308.11(d)(40)",
      "id": "2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7537",
      "citation": "21 CFR 1308.11(d)(56)",
      "id": "2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | (7537) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9758",
      "citation": "21 CFR 1308.11(b)(78)",
      "id": "2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(78) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | 9758 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7385",
      "citation": "21 CFR 1308.11(d)(42)",
      "id": "2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7518",
      "citation": "21 CFR 1308.11(d)(41)",
      "id": "2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7538",
      "citation": "21 CFR 1308.11(d)(55)",
      "id": "2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | (7538) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9772",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(85)",
      "id": "2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(85) 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | 9772 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7532",
      "citation": "21 CFR 1308.11(d)(43)",
      "id": "2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9762",
      "citation": "21 CFR 1308.11(b)(79)",
      "id": "2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(79) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | 9762 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2,5-dimethoxy-4-ethylamphet-amine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7399",
      "citation": "21 CFR 1308.11(d)(5)",
      "id": "2-5-dimethoxy-4-ethylamphet-amine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxy-4-ethylamphet-amine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7348",
      "citation": "21 CFR 1308.11(d)(6)",
      "id": "2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2,5-dimethoxyamphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7396",
      "citation": "21 CFR 1308.11(d)(4)",
      "id": "2-5-dimethoxyamphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxyamphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) 2,5-dimethoxyamphetamine | 7396 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9861",
      "citation": "21 CFR 1308.11(b)(37)",
      "id": "2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(37) 2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | 9861 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(27)",
      "id": "2-17-dimethyl-17-hydroxy-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-17-dimethyl-17-hydroxy-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(27) 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)",
      "schedule": "Schedule IV",
      "category": "Narcotic drugs",
      "dea_code_number": "9752",
      "citation": "21 CFR 1308.14(b)(3)",
      "id": "2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | 9752 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7286",
      "citation": "21 CFR 1308.11(d)(100)",
      "id": "2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | 7286 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9855",
      "citation": "21 CFR 1308.11(b)(48)",
      "id": "2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(48) 2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl) | 9855 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "7284",
      "temporary_expiry": "May 22, 2028",
      "citation": "21 CFR 1308.11(h)(87)",
      "id": "2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(87) 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | 7284 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9664",
      "citation": "21 CFR 1308.11(b)(64)",
      "id": "2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(64) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | 9664 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1259",
      "citation": "21 CFR 1308.11(d)(104)",
      "id": "2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | 1259 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "2-(methylamino)-1-phenylpentan-1-one (pentedrone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1246",
      "citation": "21 CFR 1308.11(d)(63)",
      "id": "2-methylamino-1-phenylpentan-1-one-pentedrone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methylamino-1-phenylpentan-1-one-pentedrone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9094",
      "temporary_expiry": "Aug. 27, 2028",
      "citation": "21 CFR 1308.11(h)(94)",
      "id": "3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(94) 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | 9094 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4,5-trimethoxy amphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7390",
      "citation": "21 CFR 1308.11(d)(14)",
      "id": "3-4-5-trimethoxy-amphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-5-trimethoxy-amphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) 3,4,5-trimethoxy amphetamine | 7390 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4-methylenedioxy amphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7400",
      "citation": "21 CFR 1308.11(d)(10)",
      "id": "3-4-methylenedioxy-amphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-amphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) 3,4-methylenedioxy amphetamine | 7400 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7404",
      "citation": "21 CFR 1308.11(d)(12)",
      "id": "3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4-Methylenedioxy-N-methylcathinone (Methylone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7540",
      "citation": "21 CFR 1308.11(d)(47)",
      "id": "3-4-methylenedioxy-n-methylcathinone-methylone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-n-methylcathinone-methylone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4-methylenedioxymethamphetamine (MDMA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7405",
      "citation": "21 CFR 1308.11(d)(11)",
      "id": "3-4-methylenedioxymethamphetamine-mdma",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxymethamphetamine-mdma/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3,4-methylenedioxypyrovalerone (MDPV)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7535",
      "citation": "21 CFR 1308.11(d)(37)",
      "id": "3-4-methylenedioxypyrovalerone-mdpv",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxypyrovalerone-mdpv/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(25)",
      "id": "3-17-dihydroxy-5-androstane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-17-dihydroxy-5-androstane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(25) 3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(26)",
      "id": "3-17-dihydroxy-5-androstane-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-17-dihydroxy-5-androstane-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(26) 3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-fluoro-N-methylcathinone (3-FMC)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1233",
      "citation": "21 CFR 1308.11(d)(66)",
      "id": "3-fluoro-n-methylcathinone-3-fmc",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-fluoro-n-methylcathinone-3-fmc/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(66) 3-fluoro-N-methylcathinone (3-FMC) | (1233) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9860",
      "citation": "21 CFR 1308.11(b)(50)",
      "id": "3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(50) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | 9860 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3\u03b2-hydroxy-estra-4,9,11-trien-17-one",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(42)",
      "id": "3-hydroxy-estra-4-9-11-trien-17-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-hydroxy-estra-4-9-11-trien-17-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(42) 3\u03b2-hydroxy-estra-4,9,11-trien-17-one;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7457",
      "citation": "21 CFR 1308.11(d)(109)",
      "id": "3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | 7457 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9813",
      "citation": "21 CFR 1308.11(b)(65)",
      "id": "3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(65) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | 9813 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9833",
      "citation": "21 CFR 1308.11(b)(66)",
      "id": "3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(66) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | 9833 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1595",
      "citation": "21 CFR 1308.11(f)(5)",
      "id": "4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) 4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | 1595 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(5)",
      "id": "4-androstenediol-3-17-dihydroxy-androst-4-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-androstenediol-3-17-dihydroxy-androst-4-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) 4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-androstenedione (androst-4-en-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(8)",
      "id": "4-androstenedione-androst-4-en-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-androstenedione-androst-4-en-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) 4-androstenedione (androst-4-en-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-anilino-N-phenethylpiperidine (ANPP)",
      "schedule": "Schedule II",
      "category": "Immediate precursors",
      "dea_code_number": "8333",
      "citation": "21 CFR 1308.12(g)(3)(i)",
      "id": "4-anilino-n-phenethylpiperidine-anpp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-anilino-n-phenethylpiperidine-anpp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) 4-anilino-N-phenethylpiperidine (ANPP) | 8333 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-bromo-2,5-dimethoxy-amphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7391",
      "citation": "21 CFR 1308.11(d)(2)",
      "id": "4-bromo-2-5-dimethoxy-amphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-bromo-2-5-dimethoxy-amphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-Bromo-2,5-dimethoxyphenethylamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7392",
      "citation": "21 CFR 1308.11(d)(3)",
      "id": "4-bromo-2-5-dimethoxyphenethylamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-bromo-2-5-dimethoxyphenethylamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(18)",
      "id": "4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(19)",
      "id": "4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(17)",
      "id": "4-chloro-17-methyl-androst-4-ene-3-17-diol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-androst-4-ene-3-17-diol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) 4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(16)",
      "id": "4-chloro-17-methyl-androsta-1-4-diene-3-17-diol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-androsta-1-4-diene-3-17-diol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) 4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7443",
      "citation": "21 CFR 1308.11(d)(99)",
      "id": "4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(99) 4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | 7443 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1239",
      "citation": "21 CFR 1308.11(d)(106)",
      "id": "4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | 1239 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(23)",
      "id": "4-dihydrotestosterone-17-hydroxy-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-dihydrotestosterone-17-hydroxy-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) 4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-fluoro-N-methylcathinone (4-FMC; flephedrone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1238",
      "citation": "21 CFR 1308.11(d)(65)",
      "id": "4-fluoro-n-methylcathinone-4-fmc-flephedrone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoro-n-methylcathinone-4-fmc-flephedrone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(65) 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | (1238) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1476",
      "citation": "21 CFR 1308.11(f)(8)",
      "id": "4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | 1476 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9824",
      "citation": "21 CFR 1308.11(b)(47)",
      "id": "4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(47) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | 9824 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(38)",
      "id": "4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(38) 4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-hydroxy-androst-4-ene-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(39)",
      "id": "4-hydroxy-androst-4-ene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxy-androst-4-ene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(39) 4-hydroxy-androst-4-ene-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(43)",
      "id": "4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(43) 4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methoxyamphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7411",
      "citation": "21 CFR 1308.11(d)(7)",
      "id": "4-methoxyamphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methoxyamphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) 4-methoxyamphetamine | 7411 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7551",
      "citation": "21 CFR 1308.11(d)(103)",
      "id": "4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP) | 7551 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methyl-2,5-dimethoxy-amphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7395",
      "citation": "21 CFR 1308.11(d)(9)",
      "id": "4-methyl-2-5-dimethoxy-amphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-2-5-dimethoxy-amphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9819",
      "citation": "21 CFR 1308.11(b)(63)",
      "id": "4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(63) 4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | 9819 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7245",
      "citation": "21 CFR 1308.11(d)(96)",
      "id": "4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(96) 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | 7245 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7446",
      "citation": "21 CFR 1308.11(d)(97)",
      "id": "4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(97) 4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | 7446 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7498",
      "citation": "21 CFR 1308.11(d)(60)",
      "id": "4-methyl-alpha-pyrrolidinopropiophenone-4-meppp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-pyrrolidinopropiophenone-4-meppp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(60) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | (7498) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methyl-N-ethylcathinone (4-MEC)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1249",
      "citation": "21 CFR 1308.11(d)(59)",
      "id": "4-methyl-n-ethylcathinone-4-mec",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-n-ethylcathinone-4-mec/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(59) 4-methyl-N-ethylcathinone (4-MEC) | (1249) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "4-methylmethcathinone (Mephedrone)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "1248",
      "citation": "21 CFR 1308.11(d)(36)",
      "id": "4-methylmethcathinone-mephedrone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methylmethcathinone-mephedrone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(36) 4-methylmethcathinone (Mephedrone) | 1248 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9096",
      "temporary_expiry": "Aug. 27, 2028",
      "citation": "21 CFR 1308.11(h)(93)",
      "id": "5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(93) 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | 9096 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5\u03b1-androstan-3,6,17-trione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(2)",
      "id": "5-androstan-3-6-17-trione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-androstan-3-6-17-trione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) 5\u03b1-androstan-3,6,17-trione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5\u03b1-androstan-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(1)",
      "id": "5-androstan-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-androstan-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) 5\u03b1-androstan-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(6)",
      "id": "5-androstenediol-3-17-dihydroxy-androst-5-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-androstenediol-3-17-dihydroxy-androst-5-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) 5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-androstenedione (androst-5-en-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(9)",
      "id": "5-androstenedione-androst-5-en-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-androstenedione-androst-5-en-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) 5-androstenedione (androst-5-en-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-methoxy-3,4-methylenedioxy-amphetamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7401",
      "citation": "21 CFR 1308.11(d)(8)",
      "id": "5-methoxy-3-4-methylenedioxy-amphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-methoxy-3-4-methylenedioxy-amphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) 5-methoxy-3,4-methylenedioxy-amphetamine | 7401 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7439",
      "citation": "21 CFR 1308.11(d)(20)",
      "id": "5-methoxy-n-n-diisopropyltryptamine-other-name-5-meo-dipt",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-methoxy-n-n-diisopropyltryptamine-other-name-5-meo-dipt/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) | 7439 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7431",
      "citation": "21 CFR 1308.11(d)(15)",
      "id": "5-methoxy-n-n-dimethyltryptamine-some-trade-or-other-names-5-methoxy-3-2-dimethy",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-methoxy-n-n-dimethyltryptamine-some-trade-or-other-names-5-methoxy-3-2-dimethy/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT | 7431 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9763",
      "citation": "21 CFR 1308.11(b)(80)",
      "id": "5-nitro-2-4-propoxybenzyl-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-nitro-2-4-propoxybenzyl-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(80) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) | 9763 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7093",
      "citation": "21 CFR 1308.11(d)(116)",
      "id": "5-pentyl-2-2-phenylpropan-2-yl-pyrido-4-3-b-indol-1-one-other-names-cumyl-pegacl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-pentyl-2-2-phenylpropan-2-yl-pyrido-4-3-b-indol-1-one-other-names-cumyl-pegacl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(116) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) | 7093 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7220",
      "citation": "21 CFR 1308.11(d)(115)",
      "id": "6-6-9-trimethyl-3-pentyl-6a-7-8-9-10-10a-hexahydro-6h-benzo-c-chromen-1-ol-other",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/6-6-9-trimethyl-3-pentyl-6a-7-8-9-10-10a-hexahydro-6h-benzo-c-chromen-1-ol-other/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(115) 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) | 7220 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "6-bromo-androsta-1,4-diene-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(13)",
      "id": "6-bromo-androsta-1-4-diene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/6-bromo-androsta-1-4-diene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) 6-bromo-androsta-1,4-diene-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "6-bromo-androstan-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(14)",
      "id": "6-bromo-androstan-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/6-bromo-androstan-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) 6-bromo-androstan-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "6\u03b1-methyl-androst-4-ene-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(53)",
      "id": "6-methyl-androst-4-ene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/6-methyl-androst-4-ene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(53) 6\u03b1-methyl-androst-4-ene-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9093",
      "temporary_expiry": "Aug. 27, 2028",
      "citation": "21 CFR 1308.11(h)(95)",
      "id": "8-1-4-chlorophenyl-ethyl-1-phenyl-1-3-8-triazaspiro-4-5-decan-4-one-its-isomers-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/8-1-4-chlorophenyl-ethyl-1-phenyl-1-3-8-triazaspiro-4-5-decan-4-one-its-isomers-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(95) 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) | 9093 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "2778",
      "temporary_expiry": "Mar. 16, 2028",
      "citation": "21 CFR 1308.11(h)(86)",
      "id": "8-bromo-1-methyl-6-phenyl-4h-benzo-f-1-2-4-triazolo-4-3-a-1-4-diazepine-its-salt",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/8-bromo-1-methyl-6-phenyl-4h-benzo-f-1-2-4-triazolo-4-3-a-1-4-diazepine-its-salt/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(86) 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) | 2778 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(31)",
      "id": "13-ethyl-17-hydroxygon-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/13-ethyl-17-hydroxygon-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(31) 13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b2-hydroxy-androstano[2,3-d]isoxazole",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(40)",
      "id": "17-hydroxy-androstano-2-3-d-isoxazole",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-hydroxy-androstano-2-3-d-isoxazole/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(40) 17\u03b2-hydroxy-androstano[2,3-d]isoxazole;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b2-hydroxy-androstano[3,2-c]isoxazole",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(41)",
      "id": "17-hydroxy-androstano-3-2-c-isoxazole",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-hydroxy-androstano-3-2-c-isoxazole/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(41) 17\u03b2-hydroxy-androstano[3,2-c]isoxazole;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(60)",
      "id": "17-methyl-1-dihydrotestosterone-17-hydroxy-17-methyl-5-androst-1-en-3-one-a-k-a-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-1-dihydrotestosterone-17-hydroxy-17-methyl-5-androst-1-en-3-one-a-k-a-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(60) 17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(55)",
      "id": "17-methyl-3-17-dihydroxy-5-androstane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-3-17-dihydroxy-5-androstane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(55) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(56)",
      "id": "17-methyl-3-17-dihydroxy-5-androstane-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-3-17-dihydroxy-5-androstane-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(56) 17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(57)",
      "id": "17-methyl-3-17-dihydroxyandrost-4-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-3-17-dihydroxyandrost-4-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(57) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(58)",
      "id": "17-methyl-4-hydroxynandrolone-17-methyl-4-hydroxy-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-4-hydroxynandrolone-17-methyl-4-hydroxy-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(58) 17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(51)",
      "id": "17-methyl-5-androstan-17-ol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-5-androstan-17-ol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(51) 17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(54)",
      "id": "17-methyl-androst-2-ene-3-17-diol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-androst-2-ene-3-17-diol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(54) 17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(50)",
      "id": "17-methyl-androsta-1-4-diene-3-17-diol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-androsta-1-4-diene-3-17-diol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(50) 17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(52)",
      "id": "17-methyl-androstan-3-hydroxyimine-17-ol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/17-methyl-androstan-3-hydroxyimine-17-ol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(52) 17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(37)",
      "id": "18a-homo-3-hydroxy-estra-2-5-10-dien-17-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/18a-homo-3-hydroxy-estra-2-5-10-dien-17-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(37) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(69)",
      "id": "19-nor-4-9-10-androstadienedione-estra-4-9-10-diene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-4-9-10-androstadienedione-estra-4-9-10-diene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(69) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(65)",
      "id": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(65) 19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(66)",
      "id": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(66) 19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-4-androstenedione (estr-4-en-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(70)",
      "id": "19-nor-4-androstenedione-estr-4-en-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-4-androstenedione-estr-4-en-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(70) 19-nor-4-androstenedione (estr-4-en-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(67)",
      "id": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(67) 19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(68)",
      "id": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(68) 19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "19-nor-5-androstenedione (estr-5-en-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(71)",
      "id": "19-nor-5-androstenedione-estr-5-en-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/19-nor-5-androstenedione-estr-5-en-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(71) 19-nor-5-androstenedione (estr-5-en-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7024",
      "citation": "21 CFR 1308.11(d)(71)",
      "id": "1-5-fluoropentyl-1h-indazol-3-yl-naphthalen-1-yl-methanone-thj-2201",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-1h-indazol-3-yl-naphthalen-1-yl-methanone-thj-2201/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(71) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) | (7024) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "\u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(24)",
      "id": "1-dihydrotestosterone-a-k-a-1-testosterone-17-hydroxy-5-androst-1-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-dihydrotestosterone-a-k-a-1-testosterone-17-hydroxy-5-androst-1-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(24) \u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7144",
      "citation": "21 CFR 1308.11(d)(48)",
      "id": "1-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-ur-144",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-ur-144/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(48) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) | (7144) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "[3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(36)",
      "id": "3-2-c-furazan-5-androstan-17-ol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-2-c-furazan-5-androstan-17-ol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(36) [3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "[3,2-c]pyrazole-androst-4-en-17\u03b2-ol",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(80)",
      "id": "3-2-c-pyrazole-androst-4-en-17-ol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-2-c-pyrazole-androst-4-en-17-ol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(80) [3,2-c]pyrazole-androst-4-en-17\u03b2-ol;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acetorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9319",
      "citation": "21 CFR 1308.11(c)(1)",
      "id": "acetorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acetorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Acetorphine | 9319 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9815",
      "citation": "21 CFR 1308.11(b)(1)",
      "id": "acetyl-alpha-methylfentanyl-n-1-1-methyl-2-phenethyl-4-piperidinyl-n-phenylaceta",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acetyl-alpha-methylfentanyl-n-1-1-methyl-2-phenethyl-4-piperidinyl-n-phenylaceta/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) | 9815 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9821",
      "citation": "21 CFR 1308.11(b)(3)",
      "id": "acetyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacetamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acetyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacetamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acetyldihydrocodeine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9051",
      "citation": "21 CFR 1308.11(c)(2)",
      "id": "acetyldihydrocodeine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acetyldihydrocodeine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Acetyldihydrocodeine | 9051 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acetylmethadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9601",
      "citation": "21 CFR 1308.11(b)(2)",
      "id": "acetylmethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acetylmethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Acetylmethadol | 9601 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9811",
      "citation": "21 CFR 1308.11(b)(4)",
      "id": "acryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacrylamide-also-known-as-acry",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/acryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacrylamide-also-known-as-acry/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) | 9811 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9551",
      "citation": "21 CFR 1308.11(b)(5)",
      "id": "ah-7921-3-4-dichloro-n-1-dimethylamino-cyclohexylmethyl-benzamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ah-7921-3-4-dichloro-n-1-dimethylamino-cyclohexylmethyl-benzamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) | 9551 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alfaxalone",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2731",
      "citation": "21 CFR 1308.14(c)(1)",
      "id": "alfaxalone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alfaxalone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Alfaxalone | 2731 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alfentanil",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9737",
      "citation": "21 CFR 1308.12(c)(1)",
      "id": "alfentanil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alfentanil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Alfentanil | 9737 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Allylprodine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9602",
      "citation": "21 CFR 1308.11(b)(6)",
      "id": "allylprodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/allylprodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Allylprodine | 9602 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alpha-ethyltryptamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7249",
      "citation": "21 CFR 1308.11(d)(1)",
      "id": "alpha-ethyltryptamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-ethyltryptamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Alpha-ethyltryptamine | 7249 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9864",
      "citation": "21 CFR 1308.11(b)(10)",
      "id": "alpha-methyl-butyryl-fentanyl-2-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-methyl-butyryl-fentanyl-2-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9864 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9814",
      "citation": "21 CFR 1308.11(b)(11)",
      "id": "alpha-methylfentanyl-n-1-alpha-methyl-beta-phenyl-ethyl-4-piperidyl-propionanili",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-methylfentanyl-n-1-alpha-methyl-beta-phenyl-ethyl-4-piperidyl-propionanili/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) | 9814 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9832",
      "citation": "21 CFR 1308.11(b)(12)",
      "id": "alpha-methylthiofentanyl-n-1-methyl-2-2-thienyl-ethyl-4-piperidinyl-n-phenylprop",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-methylthiofentanyl-n-1-methyl-2-2-thienyl-ethyl-4-piperidinyl-n-phenylprop/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) | 9832 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alpha-methyltryptamine (other name: AMT)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7432",
      "citation": "21 CFR 1308.11(d)(16)",
      "id": "alpha-methyltryptamine-other-name-amt",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-methyltryptamine-other-name-amt/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) Alpha-methyltryptamine (other name: AMT) | 7432 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-pyrrolidinobutiophenone (\u03b1-PBP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7546",
      "citation": "21 CFR 1308.11(d)(68)",
      "id": "alpha-pyrrolidinobutiophenone-pbp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-pyrrolidinobutiophenone-pbp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(68) alpha-pyrrolidinobutiophenone (\u03b1-PBP) | (7546) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7548",
      "citation": "21 CFR 1308.11(d)(98)",
      "id": "alpha-pyrrolidinoheptaphenone-other-names-pv8-1-phenyl-2-pyrrolidin-1-yl-heptan-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-pyrrolidinoheptaphenone-other-names-pv8-1-phenyl-2-pyrrolidin-1-yl-heptan-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(98) alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) | 7548 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7544",
      "citation": "21 CFR 1308.11(d)(95)",
      "id": "alpha-pyrrolidinohexanophenone-other-names-php-pyrrolidinohexanophenone-1-phenyl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-pyrrolidinohexanophenone-other-names-php-pyrrolidinohexanophenone-1-phenyl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(95) alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) | 7544 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "alpha-pyrrolidinopentiophenone (\u03b1-PVP)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7545",
      "citation": "21 CFR 1308.11(d)(61)",
      "id": "alpha-pyrrolidinopentiophenone-pvp",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alpha-pyrrolidinopentiophenone-pvp/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(61) alpha-pyrrolidinopentiophenone (\u03b1-PVP) | (7545) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9603",
      "citation": "21 CFR 1308.11(b)(7)",
      "id": "alphacetylmethadol-except-levo-alphacetylmethadol-also-known-as-levo-alpha-acety",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alphacetylmethadol-except-levo-alphacetylmethadol-also-known-as-levo-alpha-acety/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) | 9603 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alphameprodine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9604",
      "citation": "21 CFR 1308.11(b)(8)",
      "id": "alphameprodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alphameprodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Alphameprodine | 9604 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alphamethadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9605",
      "citation": "21 CFR 1308.11(b)(9)",
      "id": "alphamethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alphamethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Alphamethadol | 9605 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alphaprodine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9010",
      "citation": "21 CFR 1308.12(c)(2)",
      "id": "alphaprodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alphaprodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Alphaprodine | 9010 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Alprazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2882",
      "citation": "21 CFR 1308.14(c)(2)",
      "id": "alprazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/alprazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Alprazolam | 2882 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1219",
      "citation": "21 CFR 1308.11(f)(1)",
      "id": "amineptine-7-10-11-dihydro-5h-dibenzo-a-d-cyclohepten-5-yl-amino-heptanoic-acid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/amineptine-7-10-11-dihydro-5h-dibenzo-a-d-cyclohepten-5-yl-amino-heptanoic-acid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) | 1219 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1585",
      "citation": "21 CFR 1308.11(f)(2)",
      "id": "aminorex-some-other-names-aminoxaphen-2-amino-5-phenyl-2-oxazoline-or-4-5-dihydr",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/aminorex-some-other-names-aminoxaphen-2-amino-5-phenyl-2-oxazoline-or-4-5-dihydr/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) | 1585 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Amobarbital",
      "schedule": "Schedule II",
      "category": "Depressants",
      "dea_code_number": "2125",
      "citation": "21 CFR 1308.12(e)(1)",
      "id": "amobarbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/amobarbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Amobarbital | 2125 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Amobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2126",
      "scope_qualifier": "Any compound, mixture or preparation containing",
      "citation": "21 CFR 1308.13(c)(1)(i)",
      "id": "amobarbital-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/amobarbital-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Amobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2126",
      "scope_qualifier": "Any suppository dosage form containing",
      "citation": "21 CFR 1308.13(c)(2)(i)",
      "id": "amobarbital-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/amobarbital-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Amphetamine, its salts, optical isomers, and salts of its optical isomers",
      "schedule": "Schedule II",
      "category": "Stimulants",
      "dea_code_number": "1100",
      "citation": "21 CFR 1308.12(d)(1)",
      "id": "amphetamine-its-salts-optical-isomers-and-salts-of-its-optical-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/amphetamine-its-salts-optical-isomers-and-salts-of-its-optical-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers | 1100 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Anileridine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9020",
      "citation": "21 CFR 1308.12(c)(3)",
      "id": "anileridine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/anileridine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Anileridine | 9020 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2012",
      "citation": "21 CFR 1308.13(c)(6)",
      "id": "any-drug-product-containing-gamma-hydroxybutyric-acid-including-its-salts-isomer",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/any-drug-product-containing-gamma-hydroxybutyric-acid-including-its-salts-isomer/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act | 2012 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "citation": "21 CFR 1308.12(b)(2)",
      "id": "any-salt-compound-derivative-or-preparation-thereof-which-is-chemically-equivale",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/any-salt-compound-derivative-or-preparation-thereof-which-is-chemically-equivale/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2100",
      "citation": "21 CFR 1308.13(c)(3)",
      "id": "any-substance-which-contains-any-quantity-of-a-derivative-of-barbituric-acid-or-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/any-substance-which-contains-any-quantity-of-a-derivative-of-barbituric-acid-or-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof | 2100 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Barbital",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2145",
      "citation": "21 CFR 1308.14(c)(3)",
      "id": "barbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/barbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Barbital | 2145 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Benzethidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9606",
      "citation": "21 CFR 1308.11(b)(13)",
      "id": "benzethidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/benzethidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Benzethidine | 9606 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Benzphetamine",
      "schedule": "Schedule III",
      "category": "Stimulants",
      "dea_code_number": "1228",
      "citation": "21 CFR 1308.13(b)(2)",
      "id": "benzphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/benzphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Benzphetamine | 1228 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Benzylmorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9052",
      "citation": "21 CFR 1308.11(c)(3)",
      "id": "benzylmorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/benzylmorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Benzylmorphine | 9052 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9831",
      "citation": "21 CFR 1308.11(b)(16)",
      "id": "beta-hydroxy-3-methylfentanyl-n-1-2-hydroxy-2-phenylethyl-3-methyl-4-piperidinyl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-hydroxy-3-methylfentanyl-n-1-2-hydroxy-2-phenylethyl-3-methyl-4-piperidinyl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) | 9831 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9830",
      "citation": "21 CFR 1308.11(b)(15)",
      "id": "beta-hydroxyfentanyl-n-1-2-hydroxy-2-phenethyl-4-piperidinyl-n-phenylpropanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-hydroxyfentanyl-n-1-2-hydroxy-2-phenethyl-4-piperidinyl-n-phenylpropanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) | 9830 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9836",
      "citation": "21 CFR 1308.11(b)(17)",
      "id": "beta-hydroxythiofentanyl-n-1-2-hydroxy-2-thiophen-2-yl-ethyl-piperidin-4-yl-n-ph",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-hydroxythiofentanyl-n-1-2-hydroxy-2-thiophen-2-yl-ethyl-piperidin-4-yl-n-ph/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) | 9836 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9856",
      "citation": "21 CFR 1308.11(b)(20)",
      "id": "beta-methyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-propionamide-als",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-methyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-propionamide-als/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl) | 9856 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9868",
      "citation": "21 CFR 1308.11(b)(21)",
      "id": "beta-methylacetyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-acetamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-methylacetyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-acetamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide) | 9868 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9842",
      "citation": "21 CFR 1308.11(b)(22)",
      "id": "beta-phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-3-diphenylpropanamide-also-kn",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/beta-phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-3-diphenylpropanamide-also-kn/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl) | 9842 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Betacetylmethadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9607",
      "citation": "21 CFR 1308.11(b)(14)",
      "id": "betacetylmethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/betacetylmethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) Betacetylmethadol | 9607 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Betameprodine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9608",
      "citation": "21 CFR 1308.11(b)(18)",
      "id": "betameprodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/betameprodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) Betameprodine | 9608 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Betamethadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9609",
      "citation": "21 CFR 1308.11(b)(19)",
      "id": "betamethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/betamethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) Betamethadol | 9609 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Betaprodine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9611",
      "citation": "21 CFR 1308.11(b)(23)",
      "id": "betaprodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/betaprodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) Betaprodine | 9611 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Bezitramide",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9800",
      "citation": "21 CFR 1308.12(c)(4)",
      "id": "bezitramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/bezitramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Bezitramide | 9800 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(10)",
      "id": "bolasterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/bolasterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(11)",
      "id": "boldenone-17-hydroxyandrost-1-4-diene-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/boldenone-17-hydroxyandrost-1-4-diene-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "boldione (androsta-1,4-diene-3,17-dione)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(12)",
      "id": "boldione-androsta-1-4-diene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/boldione-androsta-1-4-diene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) boldione (androsta-1,4-diene-3,17-dione);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Brexanolone",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2400",
      "citation": "21 CFR 1308.14(c)(4)",
      "id": "brexanolone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/brexanolone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Brexanolone | 2400 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts)",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2710",
      "citation": "21 CFR 1308.15(e)(1)",
      "id": "brivaracetam-2s-2-4r-2-oxo-4-propylpyrrolidin-1-yl-butanamide-also-referred-to-a",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/brivaracetam-2s-2-4r-2-oxo-4-propylpyrrolidin-1-yl-butanamide-also-referred-to-a/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) | 2710 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Bromazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2748",
      "citation": "21 CFR 1308.14(c)(5)",
      "id": "bromazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/bromazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Bromazepam | 2748 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9098",
      "citation": "21 CFR 1308.11(b)(24)",
      "id": "brorphine-1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidaz",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/brorphine-1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidaz/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(24) brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) | 9098 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Bufotenine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7433",
      "citation": "21 CFR 1308.11(d)(17)",
      "id": "bufotenine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/bufotenine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) Bufotenine | 7433 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Bulk dextropropoxyphene (non-dosage forms)",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9273",
      "citation": "21 CFR 1308.12(c)(5)",
      "id": "bulk-dextropropoxyphene-non-dosage-forms",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/bulk-dextropropoxyphene-non-dosage-forms/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Bulk dextropropoxyphene (non-dosage forms) | 9273 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Buprenorphine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9064",
      "citation": "21 CFR 1308.13(e)(2)(i)",
      "id": "buprenorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/buprenorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) Buprenorphine | 9064 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9751",
      "citation": "21 CFR 1308.11(b)(25)",
      "id": "butonitazene-2-2-4-butoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/butonitazene-2-2-4-butoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(25) Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) | 9751 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Butorphanol (including its optical isomers)",
      "schedule": "Schedule IV",
      "category": "Other substances",
      "dea_code_number": "9720",
      "citation": "21 CFR 1308.14(g)(2)",
      "id": "butorphanol-including-its-optical-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/butorphanol-including-its-optical-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Butorphanol (including its optical isomers) | 9720 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9822",
      "citation": "21 CFR 1308.11(b)(26)",
      "id": "butyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbutyramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/butyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbutyramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(26) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) | 9822 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(15)",
      "id": "calusterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/calusterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Camazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2749",
      "citation": "21 CFR 1308.14(c)(6)",
      "id": "camazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/camazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Camazepam | 2749 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cannabimimetic agents",
      "schedule": "Schedule I",
      "category": "Cannabimimetic agents",
      "dea_code_number": "7000",
      "citation": "21 CFR 1308.11(g)(1)",
      "id": "cannabimimetic-agents",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cannabimimetic-agents/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Cannabimimetic agents | 7000 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Carfentanil",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9743",
      "citation": "21 CFR 1308.12(c)(6)",
      "id": "carfentanil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/carfentanil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Carfentanil | 9743 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Carisoprodol",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "8192",
      "citation": "21 CFR 1308.14(c)(7)",
      "id": "carisoprodol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/carisoprodol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Carisoprodol | 8192 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cathine ((+)-norpseudoephedrine)",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1230",
      "citation": "21 CFR 1308.14(f)(1)",
      "id": "cathine-norpseudoephedrine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cathine-norpseudoephedrine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Cathine ((+)-norpseudoephedrine) | 1230 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cathinone",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1235",
      "citation": "21 CFR 1308.11(f)(4)",
      "id": "cathinone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cathinone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Cathinone | 1235 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2720",
      "citation": "21 CFR 1308.15(e)(2)",
      "id": "cenobamate-1r-1-2-chlorophenyl-2-tetrazol-2-yl-ethyl-carbamate-2h-tetrazole-2-et",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cenobamate-1r-1-2-chlorophenyl-2-tetrazol-2-yl-ethyl-carbamate-2h-tetrazole-2-et/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) | 2720 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Chloral betaine",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2460",
      "citation": "21 CFR 1308.14(c)(8)",
      "id": "chloral-betaine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/chloral-betaine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Chloral betaine | 2460 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Chloral hydrate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2465",
      "citation": "21 CFR 1308.14(c)(9)",
      "id": "chloral-hydrate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/chloral-hydrate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Chloral hydrate | 2465 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Chlordiazepoxide",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2744",
      "citation": "21 CFR 1308.14(c)(10)",
      "id": "chlordiazepoxide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/chlordiazepoxide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Chlordiazepoxide | 2744 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Chlorhexadol",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2510",
      "citation": "21 CFR 1308.13(c)(4)",
      "id": "chlorhexadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/chlorhexadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Chlorhexadol | 2510 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Chlorphentermine",
      "schedule": "Schedule III",
      "category": "Stimulants",
      "dea_code_number": "1645",
      "citation": "21 CFR 1308.13(b)(3)",
      "id": "chlorphentermine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/chlorphentermine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Chlorphentermine | 1645 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cipepofol",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2139",
      "citation": "21 CFR 1308.14(c)(11)",
      "id": "cipepofol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cipepofol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Cipepofol | 2139 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "(\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1590",
      "citation": "21 CFR 1308.11(f)(12)",
      "id": "cis-4-methylaminorex-cis-4-5-dihydro-4-methyl-5-phenyl-2-oxazolamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cis-4-methylaminorex-cis-4-5-dihydro-4-methyl-5-phenyl-2-oxazolamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) (\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) | 1590 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clobazam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2751",
      "citation": "21 CFR 1308.14(c)(12)",
      "id": "clobazam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clobazam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) Clobazam | 2751 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clonazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2737",
      "citation": "21 CFR 1308.14(c)(13)",
      "id": "clonazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clonazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Clonazepam | 2737 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2786",
      "citation": "21 CFR 1308.11(e)(1)",
      "id": "clonazolam-other-name-6-2-chlorophenyl-1-methyl-8-nitro-4h-benzo-f-1-2-4-triazol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clonazolam-other-name-6-2-chlorophenyl-1-methyl-8-nitro-4h-benzo-f-1-2-4-triazol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2786 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clonitazene",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9612",
      "citation": "21 CFR 1308.11(b)(27)",
      "id": "clonitazene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clonitazene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(27) Clonitazene | 9612 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clorazepate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2768",
      "citation": "21 CFR 1308.14(c)(14)",
      "id": "clorazepate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clorazepate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) Clorazepate | 2768 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clortermine",
      "schedule": "Schedule III",
      "category": "Stimulants",
      "dea_code_number": "1647",
      "citation": "21 CFR 1308.13(b)(4)",
      "id": "clortermine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clortermine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Clortermine | 1647 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(20)",
      "id": "clostebol-4-chloro-17-hydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clostebol-4-chloro-17-hydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Clotiazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2752",
      "citation": "21 CFR 1308.14(c)(15)",
      "id": "clotiazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/clotiazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) Clotiazepam | 2752 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cloxazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2753",
      "citation": "21 CFR 1308.14(c)(16)",
      "id": "cloxazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cloxazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) Cloxazolam | 2753 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Coca leaves",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9040",
      "citation": "21 CFR 1308.12(b)(4)",
      "id": "coca-leaves",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/coca-leaves/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "Coca leaves (9040)",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "cocaine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9041",
      "citation": "21 CFR 1308.12(b)(4)",
      "id": "cocaine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cocaine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "cocaine (9041)",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Codeine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9050",
      "citation": "21 CFR 1308.12(b)(1)(i)",
      "id": "codeine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) Codeine | 9050 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "codeine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9803",
      "scope_qualifier": "Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium",
      "citation": "21 CFR 1308.13(e)(1)(i)",
      "id": "codeine-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium | 9803 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "codeine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9804",
      "scope_qualifier": "Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts",
      "citation": "21 CFR 1308.13(e)(1)(ii)",
      "id": "codeine-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9804 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "codeine",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams",
      "citation": "21 CFR 1308.15(c)(1)",
      "id": "codeine-4",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine-4/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Codeine methylbromide",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9070",
      "citation": "21 CFR 1308.11(c)(4)",
      "id": "codeine-methylbromide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine-methylbromide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Codeine methylbromide | 9070 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Codeine-N-Oxide",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9053",
      "citation": "21 CFR 1308.11(c)(5)",
      "id": "codeine-n-oxide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/codeine-n-oxide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Codeine-N-Oxide | 9053 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Concentrate of poppy straw",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9670",
      "citation": "21 CFR 1308.12(b)(5)",
      "id": "concentrate-of-poppy-straw",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/concentrate-of-poppy-straw/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9844",
      "citation": "21 CFR 1308.11(b)(28)",
      "id": "crotonyl-fentanyl-e-n-1-phenethylpiperidin-4-yl-n-phenylbut-2-enamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/crotonyl-fentanyl-e-n-1-phenethylpiperidin-4-yl-n-phenylbut-2-enamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(28) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) | 9844 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9847",
      "citation": "21 CFR 1308.11(b)(29)",
      "id": "cyclopentyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopentanecarboxamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cyclopentyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopentanecarboxamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(29) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) | 9847 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9845",
      "citation": "21 CFR 1308.11(b)(30)",
      "id": "cyclopropyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopropanecarboxamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cyclopropyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopropanecarboxamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) | 9845 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Cyprenorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9054",
      "citation": "21 CFR 1308.11(c)(6)",
      "id": "cyprenorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/cyprenorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Cyprenorphine | 9054 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Daridorexant",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2410",
      "citation": "21 CFR 1308.14(c)(17)",
      "id": "daridorexant",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/daridorexant/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) Daridorexant | 2410 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(21)",
      "id": "dehydrochloromethyltestosterone-4-chloro-17-hydroxy-17-methyl-androst-1-4-dien-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dehydrochloromethyltestosterone-4-chloro-17-hydroxy-17-methyl-androst-1-4-dien-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Delorazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2754",
      "citation": "21 CFR 1308.14(c)(18)",
      "id": "delorazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/delorazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) Delorazepam | 2754 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Desomorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9055",
      "citation": "21 CFR 1308.11(c)(7)",
      "id": "desomorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/desomorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Desomorphine | 9055 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(22)",
      "id": "desoxymethyltestosterone-17-methyl-5-androst-2-en-17-ol-a-k-a-madol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/desoxymethyltestosterone-17-methyl-5-androst-2-en-17-ol-a-k-a-madol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dextromoramide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9613",
      "citation": "21 CFR 1308.11(b)(31)",
      "id": "dextromoramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dextromoramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(31) Dextromoramide | 9613 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)",
      "schedule": "Schedule IV",
      "category": "Narcotic drugs",
      "dea_code_number": "9278",
      "citation": "21 CFR 1308.14(b)(2)",
      "id": "dextropropoxyphene-alpha-4-dimethylamino-1-2-diphenyl-3-methyl-2-propionoxybutan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dextropropoxyphene-alpha-4-dimethylamino-1-2-diphenyl-3-methyl-2-propionoxybutan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) | 9278 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diampromide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9615",
      "citation": "21 CFR 1308.11(b)(32)",
      "id": "diampromide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diampromide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(32) Diampromide | 9615 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2765",
      "citation": "21 CFR 1308.14(c)(19)",
      "id": "diazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) Diazepam | 2765 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dichloralphenazone",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2467",
      "citation": "21 CFR 1308.14(c)(20)",
      "id": "dichloralphenazone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dichloralphenazone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) Dichloralphenazone | 2467 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2789",
      "citation": "21 CFR 1308.11(e)(2)",
      "id": "diclazepam-other-name-7-chloro-5-2-chlorophenyl-1-methyl-1-3-dihydro-2h-benzo-e-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diclazepam-other-name-7-chloro-5-2-chlorophenyl-1-methyl-1-3-dihydro-2h-benzo-e-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) | 2789 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diethylpropion",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1610",
      "citation": "21 CFR 1308.14(f)(2)",
      "id": "diethylpropion",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diethylpropion/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Diethylpropion | 1610 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diethylthiambutene",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9616",
      "citation": "21 CFR 1308.11(b)(33)",
      "id": "diethylthiambutene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diethylthiambutene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(33) Diethylthiambutene | 9616 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diethyltryptamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7434",
      "citation": "21 CFR 1308.11(d)(18)",
      "id": "diethyltryptamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diethyltryptamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) Diethyltryptamine | 7434 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Difenoxin",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9168",
      "citation": "21 CFR 1308.11(b)(34)",
      "id": "difenoxin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/difenoxin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(34) Difenoxin | 9168 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "difenoxin",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit",
      "citation": "21 CFR 1308.15(c)(6)",
      "id": "difenoxin-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/difenoxin-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dihydrocodeine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9120",
      "citation": "21 CFR 1308.12(c)(7)",
      "id": "dihydrocodeine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dihydrocodeine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Dihydrocodeine | 9120 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "dihydrocodeine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9807",
      "scope_qualifier": "Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts",
      "citation": "21 CFR 1308.13(e)(1)(iii)",
      "id": "dihydrocodeine-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dihydrocodeine-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(iii) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts | 9807 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "dihydrocodeine",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams",
      "citation": "21 CFR 1308.15(c)(2)",
      "id": "dihydrocodeine-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dihydrocodeine-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dihydroetorphine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9334",
      "citation": "21 CFR 1308.12(b)(1)(ii)",
      "id": "dihydroetorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dihydroetorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(ii) Dihydroetorphine | 9334 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dihydromorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9145",
      "citation": "21 CFR 1308.11(c)(8)",
      "id": "dihydromorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dihydromorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Dihydromorphine | 9145 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dimenoxadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9617",
      "citation": "21 CFR 1308.11(b)(35)",
      "id": "dimenoxadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dimenoxadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(35) Dimenoxadol | 9617 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dimepheptanol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9618",
      "citation": "21 CFR 1308.11(b)(36)",
      "id": "dimepheptanol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dimepheptanol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(36) Dimepheptanol | 9618 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dimethylthiambutene",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9619",
      "citation": "21 CFR 1308.11(b)(38)",
      "id": "dimethylthiambutene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dimethylthiambutene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(38) Dimethylthiambutene | 9619 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dimethyltryptamine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7435",
      "citation": "21 CFR 1308.11(d)(19)",
      "id": "dimethyltryptamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dimethyltryptamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) Dimethyltryptamine | 7435 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dioxaphetyl butyrate",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9621",
      "citation": "21 CFR 1308.11(b)(39)",
      "id": "dioxaphetyl-butyrate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dioxaphetyl-butyrate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(39) Dioxaphetyl butyrate | 9621 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Diphenoxylate",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9170",
      "citation": "21 CFR 1308.12(c)(8)",
      "id": "diphenoxylate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diphenoxylate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Diphenoxylate | 9170 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "diphenoxylate",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit",
      "citation": "21 CFR 1308.15(c)(4)",
      "id": "diphenoxylate-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/diphenoxylate-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dipipanone",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9622",
      "citation": "21 CFR 1308.11(b)(40)",
      "id": "dipipanone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dipipanone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(40) Dipipanone | 9622 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]",
      "schedule": "Schedule II",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7365",
      "scope_qualifier": "in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration",
      "citation": "21 CFR 1308.12(f)(2)",
      "id": "dronabinol-delta-9-trans-tetrahydrocannabinol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dronabinol-delta-9-trans-tetrahydrocannabinol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration | (7365) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Dronabinol (synthetic)",
      "schedule": "Schedule III",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7369",
      "scope_qualifier": "in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product",
      "citation": "21 CFR 1308.13(g)(1)",
      "id": "dronabinol-synthetic",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/dronabinol-synthetic/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product\u20147369. [Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol]",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(28)",
      "id": "drostanolone-17-hydroxy-2-methyl-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/drostanolone-17-hydroxy-2-methyl-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(28) drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Drotebanol",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9335",
      "citation": "21 CFR 1308.11(c)(9)",
      "id": "drotebanol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/drotebanol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Drotebanol | 9335 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ecgonine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9180",
      "citation": "21 CFR 1308.12(b)(4)",
      "id": "ecgonine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ecgonine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "ecgonine (9180)",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers",
      "schedule": "Schedule IV",
      "category": "Other substances",
      "dea_code_number": "9725",
      "citation": "21 CFR 1308.14(g)(3)",
      "id": "eluxadoline-5-2s-2-amino-3-4-aminocarbonyl-2-6-dimethylphenyl-1-oxopropyl-1s-1-4",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/eluxadoline-5-2s-2-amino-3-4-aminocarbonyl-2-6-dimethylphenyl-1-oxopropyl-1s-1-4/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers (9725). |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Embutramide",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2020",
      "citation": "21 CFR 1308.13(c)(5)",
      "id": "embutramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/embutramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Embutramide | 2020 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Estazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2756",
      "citation": "21 CFR 1308.14(c)(21)",
      "id": "estazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/estazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) Estazolam | 2756 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "estra-4,9,11-triene-3,17-dione",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(30)",
      "id": "estra-4-9-11-triene-3-17-dione",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/estra-4-9-11-triene-3-17-dione/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) estra-4,9,11-triene-3,17-dione;",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethchlorvynol",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2540",
      "citation": "21 CFR 1308.14(c)(22)",
      "id": "ethchlorvynol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethchlorvynol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) Ethchlorvynol | 2540 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethinamate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2545",
      "citation": "21 CFR 1308.14(c)(23)",
      "id": "ethinamate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethinamate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) Ethinamate | 2545 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7036",
      "citation": "21 CFR 1308.11(d)(89)",
      "id": "ethyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-n",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-n/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(89) ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA) | 7036 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7094",
      "citation": "21 CFR 1308.11(d)(113)",
      "id": "ethyl-2-1-5-fluoropentyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethyl-2-1-5-fluoropentyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(113) Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201) | 7094 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethyl loflazepate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2758",
      "citation": "21 CFR 1308.14(c)(24)",
      "id": "ethyl-loflazepate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethyl-loflazepate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(24) Ethyl loflazepate | 2758 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethylamine analog of phencyclidine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7455",
      "citation": "21 CFR 1308.11(d)(32)",
      "id": "ethylamine-analog-of-phencyclidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylamine-analog-of-phencyclidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(32) Ethylamine analog of phencyclidine | 7455 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(32)",
      "id": "ethylestrenol-17-ethyl-17-hydroxyestr-4-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylestrenol-17-ethyl-17-hydroxyestr-4-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(32) ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethylmethylthiambutene",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9623",
      "citation": "21 CFR 1308.11(b)(41)",
      "id": "ethylmethylthiambutene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylmethylthiambutene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(41) Ethylmethylthiambutene | 9623 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethylmorphine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9190",
      "citation": "21 CFR 1308.12(b)(1)(iii)",
      "id": "ethylmorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylmorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(iii) Ethylmorphine | 9190 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ethylmorphine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9808",
      "scope_qualifier": "Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts",
      "citation": "21 CFR 1308.13(e)(1)(iv)",
      "id": "ethylmorphine-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylmorphine-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9808 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ethylmorphine",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams",
      "citation": "21 CFR 1308.15(c)(3)",
      "id": "ethylmorphine-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylmorphine-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1727",
      "citation": "21 CFR 1308.11(f)(6)",
      "id": "ethylphenidate-ethyl-2-phenyl-2-piperidin-2-yl-acetate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ethylphenidate-ethyl-2-phenyl-2-piperidin-2-yl-acetate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2780",
      "citation": "21 CFR 1308.11(e)(3)",
      "id": "etizolam-other-name-4-2-chlorophenyl-2-ethyl-9-methyl-6h-thieno-3-2-f-1-2-4-tria",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/etizolam-other-name-4-2-chlorophenyl-2-ethyl-9-methyl-6h-thieno-3-2-f-1-2-4-tria/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2780 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Etonitazene",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9624",
      "citation": "21 CFR 1308.11(b)(43)",
      "id": "etonitazene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/etonitazene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(43) Etonitazene | 9624 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Etorphine (except hydrochloride salt)",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9056",
      "citation": "21 CFR 1308.11(c)(10)",
      "id": "etorphine-except-hydrochloride-salt",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/etorphine-except-hydrochloride-salt/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Etorphine (except hydrochloride salt) | 9056 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Etorphine hydrochloride",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9059",
      "citation": "21 CFR 1308.12(b)(1)(iv)",
      "id": "etorphine-hydrochloride",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/etorphine-hydrochloride/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(iv) Etorphine hydrochloride | 9059 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Etoxeridine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9625",
      "citation": "21 CFR 1308.11(b)(44)",
      "id": "etoxeridine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/etoxeridine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(44) Etoxeridine | 9625 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2779",
      "citation": "21 CFR 1308.15(e)(3)",
      "id": "ezogabine-n-2-amino-4-4-fluorobenzylamino-phenyl-carbamic-acid-ethyl-ester",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ezogabine-n-2-amino-4-4-fluorobenzylamino-phenyl-carbamic-acid-ethyl-ester/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] | 2779 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fencamfamin",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1760",
      "citation": "21 CFR 1308.14(f)(3)",
      "id": "fencamfamin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fencamfamin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Fencamfamin | 1760 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fenethylline",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1503",
      "citation": "21 CFR 1308.11(f)(7)",
      "id": "fenethylline",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fenethylline/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Fenethylline | 1503 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fenproporex",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1575",
      "citation": "21 CFR 1308.14(f)(4)",
      "id": "fenproporex",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fenproporex/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Fenproporex | 1575 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fentanyl",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9801",
      "citation": "21 CFR 1308.12(c)(9)",
      "id": "fentanyl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fentanyl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Fentanyl | 9801 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9851",
      "citation": "21 CFR 1308.11(b)(45)",
      "id": "fentanyl-carbamate-ethyl-1-phenethylpiperidin-4-yl-phenyl-carbamate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fentanyl-carbamate-ethyl-1-phenethylpiperidin-4-yl-phenyl-carbamate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(45) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) | 9851 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9850",
      "citation": "21 CFR 1308.11(h)(30)",
      "id": "fentanyl-related-substances-their-isomers-esters-ethers-salts-and-salts-of-isome",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fentanyl-related-substances-their-isomers-esters-ethers-salts-and-salts-of-isome/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers | 9850 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2785",
      "citation": "21 CFR 1308.11(e)(4)",
      "id": "flualprazolam-other-name-8-chloro-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tri",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/flualprazolam-other-name-8-chloro-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tri/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2785 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2788",
      "citation": "21 CFR 1308.11(e)(5)",
      "id": "flubromazolam-other-name-8-bromo-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tria",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/flubromazolam-other-name-8-bromo-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tria/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2788 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fludiazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2759",
      "citation": "21 CFR 1308.14(c)(25)",
      "id": "fludiazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fludiazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(25) Fludiazepam | 2759 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9756",
      "citation": "21 CFR 1308.11(b)(46)",
      "id": "flunitazene-n-n-diethyl-2-2-4-fluorobenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-1-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/flunitazene-n-n-diethyl-2-2-4-fluorobenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-1-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(46) Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9756 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Flunitrazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2763",
      "citation": "21 CFR 1308.14(c)(26)",
      "id": "flunitrazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/flunitrazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(26) Flunitrazepam | 2763 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(33)",
      "id": "fluoxymesterone-9-fluoro-17-methyl-11-17-dihydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fluoxymesterone-9-fluoro-17-methyl-11-17-dihydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(33) fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Flurazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2767",
      "citation": "21 CFR 1308.14(c)(27)",
      "id": "flurazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/flurazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(27) Flurazepam | 2767 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(34)",
      "id": "formebolone-2-formyl-17-methyl-11-17-dihydroxyandrost-1-4-dien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/formebolone-2-formyl-17-methyl-11-17-dihydroxyandrost-1-4-dien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(34) formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Fospropofol",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2138",
      "citation": "21 CFR 1308.14(c)(28)",
      "id": "fospropofol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/fospropofol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(28) Fospropofol | 2138 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9834",
      "citation": "21 CFR 1308.11(b)(49)",
      "id": "furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-2-carboxamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-2-carboxamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(49) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | 9834 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(35)",
      "id": "furazabol-17-methyl-17-hydroxyandrostano-2-3-c-furazan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/furazabol-17-methyl-17-hydroxyandrostano-2-3-c-furazan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(35) furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Furethidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9626",
      "citation": "21 CFR 1308.11(b)(51)",
      "id": "furethidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/furethidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(51) Furethidine | 9626 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate)",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2010",
      "citation": "21 CFR 1308.11(e)(6)",
      "id": "gamma-hydroxybutyric-acid-some-other-names-include-ghb-gamma-hydroxybutyrate-4-h",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/gamma-hydroxybutyric-acid-some-other-names-include-ghb-gamma-hydroxybutyrate-4-h/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) | 2010 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one)",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2401",
      "citation": "21 CFR 1308.15(e)(4)",
      "id": "ganaxolone-3-hydroxy-3-methyl-5-pregnan-20-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ganaxolone-3-hydroxy-3-methyl-5-pregnan-20-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one) | 2401 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Glutethimide",
      "schedule": "Schedule II",
      "category": "Depressants",
      "dea_code_number": "2550",
      "citation": "21 CFR 1308.12(e)(2)",
      "id": "glutethimide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/glutethimide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Glutethimide | 2550 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Granulated opium",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9640",
      "citation": "21 CFR 1308.12(b)(1)(v)",
      "id": "granulated-opium",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/granulated-opium/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(v) Granulated opium | 9640 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Halazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2762",
      "citation": "21 CFR 1308.14(c)(29)",
      "id": "halazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/halazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(29) Halazepam | 2762 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Haloxazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2771",
      "citation": "21 CFR 1308.14(c)(30)",
      "id": "haloxazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/haloxazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) Haloxazolam | 2771 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Heroin",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9200",
      "citation": "21 CFR 1308.11(c)(11)",
      "id": "heroin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/heroin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Heroin | 9200 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Hydrocodone",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9193",
      "citation": "21 CFR 1308.12(b)(1)(vi)",
      "id": "hydrocodone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/hydrocodone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(vi) Hydrocodone | 9193 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Hydromorphinol",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9301",
      "citation": "21 CFR 1308.11(c)(12)",
      "id": "hydromorphinol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/hydromorphinol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) Hydromorphinol | 9301 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Hydromorphone",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9150",
      "citation": "21 CFR 1308.12(b)(1)(vii)",
      "id": "hydromorphone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/hydromorphone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(vii) Hydromorphone | 9150 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Hydroxypethidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9627",
      "citation": "21 CFR 1308.11(b)(52)",
      "id": "hydroxypethidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/hydroxypethidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(52) Hydroxypethidine | 9627 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ibogaine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7260",
      "citation": "21 CFR 1308.11(d)(21)",
      "id": "ibogaine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ibogaine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) Ibogaine | 7260 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9827",
      "citation": "21 CFR 1308.11(b)(53)",
      "id": "isobutyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylisobutyramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/isobutyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylisobutyramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(53) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) | 9827 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Isomethadone",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9226",
      "citation": "21 CFR 1308.12(c)(10)",
      "id": "isomethadone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/isomethadone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Isomethadone | 9226 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9614",
      "citation": "21 CFR 1308.11(b)(54)",
      "id": "isotonitazene-n-n-diethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-1-yl-et",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/isotonitazene-n-n-diethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-1-yl-et/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(54) Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9614 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9862",
      "citation": "21 CFR 1308.11(b)(55)",
      "id": "isovaleryl-fentanyl-3-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/isovaleryl-fentanyl-3-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(55) Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9862 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ketamine, its salts, isomers, and salts of isomers",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "7285",
      "citation": "21 CFR 1308.13(c)(7)",
      "id": "ketamine-its-salts-isomers-and-salts-of-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ketamine-its-salts-isomers-and-salts-of-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Ketamine, its salts, isomers, and salts of isomers | 7285 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ketazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2772",
      "citation": "21 CFR 1308.14(c)(31)",
      "id": "ketazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ketazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(31) Ketazolam | 2772 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ketobemidone",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9628",
      "citation": "21 CFR 1308.11(b)(56)",
      "id": "ketobemidone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ketobemidone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(56) Ketobemidone | 9628 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2746",
      "citation": "21 CFR 1308.15(e)(5)",
      "id": "lacosamide-r-2-acetoamido-n-benzyl-3-methoxy-propionamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lacosamide-r-2-acetoamido-n-benzyl-3-methoxy-propionamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] | 2746 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2790",
      "citation": "21 CFR 1308.15(e)(6)",
      "id": "lasmiditan-2-4-6-trifluoro-n-6-1-methylpiperidine-4-carbonyl-pyridine-2-yl-benza",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lasmiditan-2-4-6-trifluoro-n-6-1-methylpiperidine-4-carbonyl-pyridine-2-yl-benza/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] | 2790 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lemborexant",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2245",
      "citation": "21 CFR 1308.14(c)(32)",
      "id": "lemborexant",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lemborexant/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(32) Lemborexant | 2245 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Levo-alphacetylmethadol",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9648",
      "citation": "21 CFR 1308.12(c)(11)",
      "id": "levo-alphacetylmethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/levo-alphacetylmethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Levo-alphacetylmethadol | 9648 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Levomethorphan",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9210",
      "citation": "21 CFR 1308.12(c)(12)",
      "id": "levomethorphan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/levomethorphan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) Levomethorphan | 9210 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Levomoramide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9629",
      "citation": "21 CFR 1308.11(b)(57)",
      "id": "levomoramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/levomoramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(57) Levomoramide | 9629 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Levophenacylmorphan",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9631",
      "citation": "21 CFR 1308.11(b)(58)",
      "id": "levophenacylmorphan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/levophenacylmorphan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(58) Levophenacylmorphan | 9631 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Levorphanol",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9220",
      "citation": "21 CFR 1308.12(c)(13)",
      "id": "levorphanol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/levorphanol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Levorphanol | 9220 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lisdexamfetamine, its salts, isomers, and salts of its isomers",
      "schedule": "Schedule II",
      "category": "Stimulants",
      "dea_code_number": "1205",
      "citation": "21 CFR 1308.12(d)(5)",
      "id": "lisdexamfetamine-its-salts-isomers-and-salts-of-its-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lisdexamfetamine-its-salts-isomers-and-salts-of-its-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Lisdexamfetamine, its salts, isomers, and salts of its isomers | 1205. |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Loprazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2773",
      "citation": "21 CFR 1308.14(c)(33)",
      "id": "loprazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/loprazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(33) Loprazolam | 2773 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lorazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2885",
      "citation": "21 CFR 1308.14(c)(34)",
      "id": "lorazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lorazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(34) Lorazepam | 2885 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lorcaserin",
      "schedule": "Schedule IV",
      "category": "Lorcaserin",
      "dea_code_number": "1625",
      "citation": "21 CFR 1308.14(e)(1)",
      "id": "lorcaserin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lorcaserin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Lorcaserin | 1625 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lormetazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2774",
      "citation": "21 CFR 1308.14(c)(35)",
      "id": "lormetazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lormetazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(35) Lormetazepam | 2774 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lysergic acid",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "7300",
      "citation": "21 CFR 1308.13(c)(8)",
      "id": "lysergic-acid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lysergic-acid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Lysergic acid | 7300 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lysergic acid amide",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "7310",
      "citation": "21 CFR 1308.13(c)(9)",
      "id": "lysergic-acid-amide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lysergic-acid-amide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Lysergic acid amide | 7310 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Lysergic acid diethylamide",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7315",
      "citation": "21 CFR 1308.11(d)(22)",
      "id": "lysergic-acid-diethylamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/lysergic-acid-diethylamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) Lysergic acid diethylamide | 7315 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Marihuana",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7360",
      "citation": "21 CFR 1308.11(d)(23)",
      "id": "marihuana",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/marihuana/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) Marihuana | 7360 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Marihuana Extract",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7350",
      "citation": "21 CFR 1308.11(d)(58)",
      "id": "marihuana-extract",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/marihuana-extract/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(58) Marihuana Extract | 7350 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Marijuana",
      "schedule": "Schedule III",
      "category": "Hallucinogenic substances",
      "scope_qualifier": "in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license",
      "citation": "21 CFR 1308.13(g)(2)",
      "id": "marijuana",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/marijuana/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Marijuana, as defined in 21 U.S.C. 802(16) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Marijuana extract",
      "schedule": "Schedule III",
      "category": "Hallucinogenic substances",
      "scope_qualifier": "in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license",
      "citation": "21 CFR 1308.13(g)(3)",
      "id": "marijuana-extract",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/marijuana-extract/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Marijuana extract, as defined in 21 CFR 1308.11(d)(58) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mazindol",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1605",
      "citation": "21 CFR 1308.14(f)(5)",
      "id": "mazindol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mazindol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Mazindol | 1605 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mebutamate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2800",
      "citation": "21 CFR 1308.14(c)(36)",
      "id": "mebutamate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mebutamate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(36) Mebutamate | 2800 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mecloqualone",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2572",
      "citation": "21 CFR 1308.11(e)(7)",
      "id": "mecloqualone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mecloqualone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Mecloqualone | 2572 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Medazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2836",
      "citation": "21 CFR 1308.14(c)(37)",
      "id": "medazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/medazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(37) Medazepam | 2836 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mefenorex",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1580",
      "citation": "21 CFR 1308.14(f)(6)",
      "id": "mefenorex",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mefenorex/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(6) Mefenorex | 1580 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Meprobamate",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2820",
      "citation": "21 CFR 1308.14(c)(388)",
      "id": "meprobamate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/meprobamate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(388) Meprobamate | 2820 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mescaline",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7381",
      "citation": "21 CFR 1308.11(d)(24)",
      "id": "mescaline",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mescaline/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(24) Mescaline | 7381 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1227",
      "citation": "21 CFR 1308.11(f)(9)",
      "id": "mesocarb-n-phenyl-n-3-1-phenylpropan-2-yl-1-2-3-oxadiazol-3-ium-5-yl-carbamimida",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mesocarb-n-phenyl-n-3-1-phenylpropan-2-yl-1-2-3-oxadiazol-3-ium-5-yl-carbamimida/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) | 1227 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(44)",
      "id": "mestanolone-17-methyl-17-hydroxy-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mestanolone-17-methyl-17-hydroxy-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(44) mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(45)",
      "id": "mesterolone-1-methyl-17-hydroxy-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mesterolone-1-methyl-17-hydroxy-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(45) mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9857",
      "citation": "21 CFR 1308.11(b)(59)",
      "id": "meta-fluorofentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/meta-fluorofentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(59) meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9857 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9871",
      "citation": "21 CFR 1308.11(b)(60)",
      "id": "meta-fluorofuranyl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/meta-fluorofuranyl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(60) meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9871 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9858",
      "citation": "21 CFR 1308.11(b)(61)",
      "id": "meta-fluoroisobutyryl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-isob",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/meta-fluoroisobutyryl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-isob/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(61) meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9858 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Metazocine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9240",
      "citation": "21 CFR 1308.12(c)(14)",
      "id": "metazocine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/metazocine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) Metazocine | 9240 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methadone",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9250",
      "citation": "21 CFR 1308.12(c)(15)",
      "id": "methadone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methadone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) Methadone | 9250 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9254",
      "citation": "21 CFR 1308.12(c)(16)",
      "id": "methadone-intermediate-4-cyano-2-dimethylamino-4-4-diphenyl-butane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methadone-intermediate-4-cyano-2-dimethylamino-4-4-diphenyl-butane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane | 9254 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methamphetamine, its salts, isomers, and salts of its isomers",
      "schedule": "Schedule II",
      "category": "Stimulants",
      "dea_code_number": "1105",
      "citation": "21 CFR 1308.12(d)(2)",
      "id": "methamphetamine-its-salts-isomers-and-salts-of-its-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methamphetamine-its-salts-isomers-and-salts-of-its-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Methamphetamine, its salts, isomers, and salts of its isomers | 1105 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(46)",
      "id": "methandienone-17-methyl-17-hydroxyandrost-1-4-dien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methandienone-17-methyl-17-hydroxyandrost-1-4-dien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(46) methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(47)",
      "id": "methandriol-17-methyl-3-17-dihydroxyandrost-5-ene",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methandriol-17-methyl-3-17-dihydroxyandrost-5-ene/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(47) methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methaqualone",
      "schedule": "Schedule I",
      "category": "Depressants",
      "dea_code_number": "2565",
      "citation": "21 CFR 1308.11(e)(8)",
      "id": "methaqualone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methaqualone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Methaqualone | 2565 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(48)",
      "id": "methasterone-2-17-dimethyl-5-androstan-17-ol-3-one-or-2-17-dimethyl-17-hydroxy-5",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methasterone-2-17-dimethyl-5-androstan-17-ol-3-one-or-2-17-dimethyl-17-hydroxy-5/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(48) methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1237",
      "citation": "21 CFR 1308.11(f)(10)",
      "id": "methcathinone-some-other-names-2-methylamino-propiophenone-alpha-methylamino-pro",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methcathinone-some-other-names-2-methylamino-propiophenone-alpha-methylamino-pro/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers | 1237 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(49)",
      "id": "methenolone-1-methyl-17-hydroxy-5-androst-1-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methenolone-1-methyl-17-hydroxy-5-androst-1-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(49) methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1478",
      "citation": "21 CFR 1308.11(f)(11)",
      "id": "methiopropamine-n-methyl-1-thiophen-2-yl-propan-2-amine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methiopropamine-n-methyl-1-thiophen-2-yl-propan-2-amine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) | 1478 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methohexital",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2264",
      "citation": "21 CFR 1308.14(c)(39)",
      "id": "methohexital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methohexital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(39) Methohexital | 2264 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9825",
      "citation": "21 CFR 1308.11(b)(62)",
      "id": "methoxyacetyl-fentanyl-2-methoxy-n-1-phenethylpiperidin-4-yl-n-phenylacetamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methoxyacetyl-fentanyl-2-methoxy-n-1-phenethylpiperidin-4-yl-n-phenylacetamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(62) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9825 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7020",
      "citation": "21 CFR 1308.11(d)(78)",
      "id": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(78) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA) | 7020 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7021",
      "citation": "21 CFR 1308.11(d)(79)",
      "id": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-methylbutanoate-fub-amb-mm",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-methylbutanoate-fub-amb-mm/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(79) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) | (7021) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7095",
      "citation": "21 CFR 1308.11(d)(114)",
      "id": "methyl-2-1-4-fluorobenzyl-1h-indole-3-carboxamido-3-methyl-butanoate-other-name-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-4-fluorobenzyl-1h-indole-3-carboxamido-3-methyl-butanoate-other-name-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(114) Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA) | 7095 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7043",
      "citation": "21 CFR 1308.11(d)(87)",
      "id": "methyl-2-1-4-fluorobutyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-4f-mdmb",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-4-fluorobutyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-4f-mdmb/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(87) methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA) | 7043 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7091",
      "citation": "21 CFR 1308.11(d)(111)",
      "id": "methyl-2-1-4-fluorobutyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-4-fluorobutyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(111) Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA) | 7091 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7034",
      "citation": "21 CFR 1308.11(d)(73)",
      "id": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(73) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA) | 7034 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7033",
      "citation": "21 CFR 1308.11(d)(74)",
      "id": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-methylbutanoate-other-name",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-methylbutanoate-other-name/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(74) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB) | 7033 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7041",
      "citation": "21 CFR 1308.11(d)(90)",
      "id": "methyl-2-1-5-fluoropentyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-na",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-5-fluoropentyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-na/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(90) methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) | 7041 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7042",
      "citation": "21 CFR 1308.11(d)(77)",
      "id": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(77) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA) | 7042 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7044",
      "citation": "21 CFR 1308.11(d)(84)",
      "id": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-methylbutanoate-other-name",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-methylbutanoate-other-name/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(84) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA) | 7044 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7090",
      "citation": "21 CFR 1308.11(d)(110)",
      "id": "methyl-3-3-dimethyl-2-1-pent-4-en-1-yl-1h-indazole-3-carboxamido-butanoate-other",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-3-3-dimethyl-2-1-pent-4-en-1-yl-1h-indazole-3-carboxamido-butanoate-other/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(110) methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA) | 7090 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9672",
      "temporary_expiry": "Aug. 26, 2028",
      "citation": "21 CFR 1308.11(h)(89)",
      "id": "methyl-e-2-1-s-6-s-7-s-6-ethyl-4-methoxy-3-oxo-3-5-6-7-8-8a-hexahydro-2-h-spiro-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-e-2-1-s-6-s-7-s-6-ethyl-4-methoxy-3-oxo-3-5-6-7-8-8a-hexahydro-2-h-spiro-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(89) Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9672 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9673",
      "temporary_expiry": "Aug. 26, 2028",
      "citation": "21 CFR 1308.11(h)(90)",
      "id": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-7a-hydroxy-8-methoxy-1-2-3-4-6-7-7a-12-12",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-7a-hydroxy-8-methoxy-1-2-3-4-6-7-7a-12-12/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9673 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9674",
      "temporary_expiry": "Aug. 26, 2028",
      "citation": "21 CFR 1308.11(h)(91)",
      "id": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1-2-3-4-6-7",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1-2-3-4-6-7/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9674 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyldesorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9302",
      "citation": "21 CFR 1308.11(c)(13)",
      "id": "methyldesorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyldesorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Methyldesorphine | 9302 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(59)",
      "id": "methyldienolone-17-methyl-17-hydroxyestra-4-9-10-dien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyldienolone-17-methyl-17-hydroxyestra-4-9-10-dien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(59) methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyldihydromorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9304",
      "citation": "21 CFR 1308.11(c)(14)",
      "id": "methyldihydromorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyldihydromorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) Methyldihydromorphine | 9304 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methylphenidate",
      "schedule": "Schedule II",
      "category": "Stimulants",
      "dea_code_number": "1724",
      "citation": "21 CFR 1308.12(d)(4)",
      "id": "methylphenidate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methylphenidate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Methylphenidate | 1724 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methylphenobarbital (mephobarbital)",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2250",
      "citation": "21 CFR 1308.14(c)(40)",
      "id": "methylphenobarbital-mephobarbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methylphenobarbital-mephobarbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(40) Methylphenobarbital (mephobarbital) | 2250 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(61)",
      "id": "methyltestosterone-17-methyl-17-hydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyltestosterone-17-methyl-17-hydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(61) methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(62)",
      "id": "methyltrienolone-17-methyl-17-hydroxyestra-4-9-11-trien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyltrienolone-17-methyl-17-hydroxyestra-4-9-11-trien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(62) methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Methyprylon",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2575",
      "citation": "21 CFR 1308.13(c)(10)",
      "id": "methyprylon",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/methyprylon/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Methyprylon | 2575 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9764",
      "citation": "21 CFR 1308.11(b)(67)",
      "id": "metodesnitazene-n-n-diethyl-2-2-4-methoxybenzyl-1h-benzimidazol-1-yl-ethan-1-ami",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/metodesnitazene-n-n-diethyl-2-2-4-methoxybenzyl-1h-benzimidazol-1-yl-ethan-1-ami/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(67) Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) | 9764 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9757",
      "citation": "21 CFR 1308.11(b)(68)",
      "id": "metonitazene-n-n-diethyl-2-2-4-methoxybenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/metonitazene-n-n-diethyl-2-2-4-methoxybenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(68) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9757 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Metopon",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9260",
      "citation": "21 CFR 1308.12(b)(1)(viii)",
      "id": "metopon",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/metopon/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(viii) Metopon | 9260 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(63)",
      "id": "mibolerone-7-17-dimethyl-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mibolerone-7-17-dimethyl-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(63) mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Midazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2884",
      "citation": "21 CFR 1308.14(c)(41)",
      "id": "midazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/midazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(41) Midazolam | 2884 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Modafinil",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1680",
      "citation": "21 CFR 1308.14(f)(7)",
      "id": "modafinil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/modafinil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7)Modafinil | 1680 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9802",
      "citation": "21 CFR 1308.12(c)(17)",
      "id": "moramide-intermediate-2-methyl-3-morpholino-1-1-diphenylpropane-carboxylic-acid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/moramide-intermediate-2-methyl-3-morpholino-1-1-diphenylpropane-carboxylic-acid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid | 9802 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Morpheridine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9632",
      "citation": "21 CFR 1308.11(b)(69)",
      "id": "morpheridine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morpheridine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(69) Morpheridine | 9632 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Morphine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9300",
      "citation": "21 CFR 1308.12(b)(1)(ix)",
      "id": "morphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(ix) Morphine | 9300 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "morphine",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9810",
      "scope_qualifier": "Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts",
      "citation": "21 CFR 1308.13(e)(1)(vi)",
      "id": "morphine-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morphine-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9810 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Morphine methylbromide",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9305",
      "citation": "21 CFR 1308.11(c)(15)",
      "id": "morphine-methylbromide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morphine-methylbromide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) Morphine methylbromide | 9305 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Morphine methylsulfonate",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9306",
      "citation": "21 CFR 1308.11(c)(16)",
      "id": "morphine-methylsulfonate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morphine-methylsulfonate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(16) Morphine methylsulfonate | 9306 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Morphine-N-Oxide",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9307",
      "citation": "21 CFR 1308.11(c)(17)",
      "id": "morphine-n-oxide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/morphine-n-oxide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(17) Morphine-N-Oxide | 9307 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9661",
      "citation": "21 CFR 1308.11(b)(70)",
      "id": "mppp-1-methyl-4-phenyl-4-propionoxypiperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mppp-1-methyl-4-phenyl-4-propionoxypiperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(70) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) | 9661 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9560",
      "citation": "21 CFR 1308.11(b)(71)",
      "id": "mt-45-1-cyclohexyl-4-1-2-diphenylethyl-piperazine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/mt-45-1-cyclohexyl-4-1-2-diphenylethyl-piperazine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(71) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Myrophine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9308",
      "citation": "21 CFR 1308.11(c)(18)",
      "id": "myrophine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/myrophine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) Myrophine | 9308 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7048",
      "citation": "21 CFR 1308.11(d)(50)",
      "id": "n-1-adamantyl-1-pentyl-1h-indazole-3-carboxamide-apinaca-akb48",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-adamantyl-1-pentyl-1h-indazole-3-carboxamide-apinaca-akb48/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(50) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48) | (7048) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7010",
      "citation": "21 CFR 1308.11(d)(76)",
      "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(76) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA) | 7010 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7027",
      "citation": "21 CFR 1308.11(d)(102)",
      "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-butyl-1h-indazole-3-carboxamide-other-n",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-butyl-1h-indazole-3-carboxamide-other-n/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(102) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA) | 7027 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7032",
      "citation": "21 CFR 1308.11(d)(72)",
      "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(72) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) | (7032) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7092",
      "citation": "21 CFR 1308.11(d)(112)",
      "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pent-4-en-1-yl-1h-indazole-3-carboxamid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pent-4-en-1-yl-1h-indazole-3-carboxamid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(112) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA) | 7092 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7035",
      "citation": "21 CFR 1308.11(d)(54)",
      "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-adb-pi",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-adb-pi/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(54) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) | (7035) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7012",
      "citation": "21 CFR 1308.11(d)(53)",
      "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-ab",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-methyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-ab/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(53) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) | (7012) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7025",
      "citation": "21 CFR 1308.11(d)(82)",
      "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-ot",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-methyl-1-oxobutan-2-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-ot/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(82) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) | 7025 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7031",
      "citation": "21 CFR 1308.11(d)(69)",
      "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxamide-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-methyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxamide-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) | (7031) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7023",
      "citation": "21 CFR 1308.11(d)(70)",
      "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-ab-pinaca",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-1-amino-3-methyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-ab-pinaca/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(70) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) | (7023) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7047",
      "citation": "21 CFR 1308.11(d)(91)",
      "id": "n-adamantan-1-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-other-names-fub-akb4",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-adamantan-1-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-other-names-fub-akb4/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(91) N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) | 7047 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7049",
      "citation": "21 CFR 1308.11(d)(75)",
      "id": "n-adamantan-1-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-other-names-5f-apina",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-adamantan-1-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-other-names-5f-apina/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(75) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48) | 7049 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "7493",
      "citation": "21 CFR 1308.11(f)(3)",
      "id": "n-benzylpiperazine-some-other-names-bzp-1-benzylpiperazine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-benzylpiperazine-some-other-names-bzp-1-benzylpiperazine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) | 7493 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9760",
      "citation": "21 CFR 1308.11(b)(72)",
      "id": "n-desethyl-isotonitazene-n-ethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-desethyl-isotonitazene-n-ethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(72) N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9760 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9769",
      "temporary_expiry": "Oct. 15, 2027",
      "citation": "21 CFR 1308.11(h)(83)",
      "id": "n-ethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-its-isome",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-ethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-its-isome/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(83) N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene) | 9769 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-ethyl-3-piperidyl benzilate",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7482",
      "citation": "21 CFR 1308.11(d)(27)",
      "id": "n-ethyl-3-piperidyl-benzilate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-ethyl-3-piperidyl-benzilate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(27) N-ethyl-3-piperidyl benzilate | 7482 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-ethylamphetamine",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1475",
      "citation": "21 CFR 1308.11(f)(13)",
      "id": "n-ethylamphetamine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-ethylamphetamine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) N-ethylamphetamine | 1475 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7246",
      "citation": "21 CFR 1308.11(d)(94)",
      "id": "n-ethylhexedrone-other-names-ethylaminohexanophenone-2-ethylamino-1-phenylhexan-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-ethylhexedrone-other-names-ethylaminohexanophenone-2-ethylamino-1-phenylhexan-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(94) N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one) | 7246 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7543",
      "citation": "21 CFR 1308.11(d)(86)",
      "id": "n-ethylpentylone-other-names-ephylone-1-1-3-benzodioxol-5-yl-2-ethylamino-pentan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-ethylpentylone-other-names-ephylone-1-1-3-benzodioxol-5-yl-2-ethylamino-pentan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(86) N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) | 7543 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7402",
      "citation": "21 CFR 1308.11(d)(13)",
      "id": "n-hydroxy-3-4-methylenedioxyamphetamine-also-known-as-n-hydroxy-alpha-methyl-3-4",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-hydroxy-3-4-methylenedioxyamphetamine-also-known-as-n-hydroxy-alpha-methyl-3-4/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA | 7402 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-methyl-3-piperidyl benzilate",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7484",
      "citation": "21 CFR 1308.11(d)(28)",
      "id": "n-methyl-3-piperidyl-benzilate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-methyl-3-piperidyl-benzilate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(28) N-methyl-3-piperidyl benzilate | 7484 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9759",
      "citation": "21 CFR 1308.11(b)(111)",
      "id": "n-n-diethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-other",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-n-diethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-other/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(111) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) | 9759 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)",
      "schedule": "Schedule I",
      "category": "Stimulants",
      "dea_code_number": "1480",
      "citation": "21 CFR 1308.11(f)(14)",
      "id": "n-n-dimethylamphetamine-also-known-as-n-n-alpha-trimethyl-benzeneethanamine-n-n-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-n-dimethylamphetamine-also-known-as-n-n-alpha-trimethyl-benzeneethanamine-n-n-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) | 1480 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)",
      "schedule": "Schedule II",
      "category": "Immediate precursors",
      "dea_code_number": "8366",
      "citation": "21 CFR 1308.12(g)(3)(ii)",
      "id": "n-phenyl-n-piperidin-4-yl-propionamide-norfentanyl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-phenyl-n-piperidin-4-yl-propionamide-norfentanyl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(ii) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) | 8366 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9761",
      "citation": "21 CFR 1308.11(b)(77)",
      "id": "n-piperidinyl-etonitazene-2-4-ethoxybenzyl-5-nitro-1-2-piperidin-1-yl-ethyl-1h-b",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/n-piperidinyl-etonitazene-2-4-ethoxybenzyl-5-nitro-1-2-piperidin-1-yl-ethyl-1h-b/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(77) N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne) | 9761 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nabilone",
      "schedule": "Schedule II",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7379",
      "citation": "21 CFR 1308.12(f)(1)",
      "id": "nabilone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nabilone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Nabilone | 7379 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nalorphine",
      "schedule": "Schedule III",
      "dea_code_number": "9400",
      "citation": "21 CFR 1308.13(d)",
      "id": "nalorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nalorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(d) Nalorphine 9400.",
      "verified_fields": [
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "nandrolone (17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(64)",
      "id": "nandrolone-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nandrolone-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(64) nandrolone (17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7221",
      "citation": "21 CFR 1308.11(d)(81)",
      "id": "naphthalen-1-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-other-names-nm2201-cbl2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/naphthalen-1-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-other-names-nm2201-cbl2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(81) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201) | 7221 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Naturally derived delta-9-tetrahydrocannabinols",
      "schedule": "Schedule III",
      "category": "Hallucinogenic substances",
      "scope_qualifier": "in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license",
      "citation": "21 CFR 1308.13(g)(4)",
      "id": "naturally-derived-delta-9-tetrahydrocannabinols",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/naturally-derived-delta-9-tetrahydrocannabinols/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Naturally derived delta-9-tetrahydrocannabinols in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license\u2014XXXX (i) Naturally derived delta-9-tetrahydrocannabinols means those delta-9-tetrahydrocannabinols, except as in paragraphs (g)(2) and (3) of this section, that are naturally contained in a plant of the genus Cannabis (cannabis plant). (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639 o. (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C. 802(16)(B)(ii) .",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nicocodeine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9309",
      "citation": "21 CFR 1308.11(c)(19)",
      "id": "nicocodeine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nicocodeine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) Nicocodeine | 9309 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nicomorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9312",
      "citation": "21 CFR 1308.11(c)(20)",
      "id": "nicomorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nicomorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) Nicomorphine | 9312 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nimetazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2837",
      "citation": "21 CFR 1308.14(c)(42)",
      "id": "nimetazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nimetazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(42) Nimetazepam | 2837 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nitrazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2834",
      "citation": "21 CFR 1308.14(c)(43)",
      "id": "nitrazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nitrazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(43) Nitrazepam | 2834 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Noracymethadol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9633",
      "citation": "21 CFR 1308.11(b)(73)",
      "id": "noracymethadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/noracymethadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(73) Noracymethadol | 9633 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(72)",
      "id": "norbolethone-13-17-diethyl-17-hydroxygon-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/norbolethone-13-17-diethyl-17-hydroxygon-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(72) norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(73)",
      "id": "norclostebol-4-chloro-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/norclostebol-4-chloro-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(73) norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Nordiazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2838",
      "citation": "21 CFR 1308.14(c)(44)",
      "id": "nordiazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/nordiazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(44) Nordiazepam | 2838 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(74)",
      "id": "norethandrolone-17-ethyl-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/norethandrolone-17-ethyl-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(74) norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Norlevorphanol",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9634",
      "citation": "21 CFR 1308.11(b)(74)",
      "id": "norlevorphanol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/norlevorphanol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(74) Norlevorphanol | 9634 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Normethadone",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9635",
      "citation": "21 CFR 1308.11(b)(75)",
      "id": "normethadone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/normethadone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(75) Normethadone | 9635 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(75)",
      "id": "normethandrolone-17-methyl-17-hydroxyestr-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/normethandrolone-17-methyl-17-hydroxyestr-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(75) normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Normorphine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9313",
      "citation": "21 CFR 1308.11(c)(21)",
      "id": "normorphine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/normorphine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) Normorphine | 9313 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Noroxymorphone",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9668",
      "citation": "21 CFR 1308.12(b)(1)(x)",
      "id": "noroxymorphone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/noroxymorphone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(x) Noroxymorphone | 9668 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Norpipanone",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9636",
      "citation": "21 CFR 1308.11(b)(76)",
      "id": "norpipanone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/norpipanone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(76) Norpipanone | 9636 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit",
      "schedule": "Schedule IV",
      "category": "Narcotic drugs",
      "dea_code_number": "9167",
      "citation": "21 CFR 1308.14(b)(1)",
      "id": "not-more-than-1-milligram-of-difenoxin-and-not-less-than-25-micrograms-of-atropi",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/not-more-than-1-milligram-of-difenoxin-and-not-less-than-25-micrograms-of-atropi/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit | 9167 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol)",
      "schedule": "Schedule I",
      "category": "Temporary listing of substances subject to emergency scheduling",
      "dea_code_number": "9667",
      "temporary_expiry": "Aug. 26, 2028",
      "citation": "21 CFR 1308.11(h)(88)",
      "id": "o-desmethyltramadol-other-names-o-dsmt-desmetramadol-3-1r-2r-2-dimethylamino-met",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/o-desmethyltramadol-other-names-o-dsmt-desmetramadol-3-1r-2r-2-dimethylamino-met/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(88) O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) | 9667 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name",
        "temporary_expiry"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9838",
      "citation": "21 CFR 1308.11(b)(81)",
      "id": "ocfentanil-n-2-fluorophenyl-2-methoxy-n-1-phenethylpiperidin-4-yl-acetamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ocfentanil-n-2-fluorophenyl-2-methoxy-n-1-phenethylpiperidin-4-yl-acetamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(81) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) | 9838 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine)",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9245",
      "citation": "21 CFR 1308.12(c)(18)",
      "id": "oliceridine-n-3-methoxythiophen-2-yl-methyl-2-9r-9-pyridin-2-yl-6-oxaspiro-4-5-d",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oliceridine-n-3-methoxythiophen-2-yl-methyl-2-9r-9-pyridin-2-yl-6-oxaspiro-4-5-d/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(18) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) | 9245 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "opium",
      "schedule": "Schedule III",
      "category": "Narcotic drugs",
      "dea_code_number": "9809",
      "scope_qualifier": "Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts",
      "citation": "21 CFR 1308.13(e)(1)(v)",
      "id": "opium",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/opium/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9809 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "opium",
      "schedule": "Schedule V",
      "category": "Narcotic drugs containing non-narcotic active medicinal ingredients",
      "scope_qualifier": "Not more than 100 milligrams of opium per 100 milliliters or per 100 grams",
      "citation": "21 CFR 1308.15(c)(5)",
      "id": "opium-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/opium-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.",
      "verified_fields": [
        "category",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Opium extracts",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9610",
      "citation": "21 CFR 1308.12(b)(1)(xi)",
      "id": "opium-extracts",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/opium-extracts/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xi) Opium extracts | 9610 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Opium fluid",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9620",
      "citation": "21 CFR 1308.12(b)(1)(xii)",
      "id": "opium-fluid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/opium-fluid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xii) Opium fluid | 9620 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Opium poppy and poppy straw",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "citation": "21 CFR 1308.12(b)(3)",
      "id": "opium-poppy-and-poppy-straw",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/opium-poppy-and-poppy-straw/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Opium poppy and poppy straw.",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oripavine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9330",
      "citation": "21 CFR 1308.12(b)(1)(xiii)",
      "id": "oripavine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oripavine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xiii) Oripavine | 9330 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9828",
      "citation": "21 CFR 1308.11(b)(82)",
      "id": "ortho-chlorofentanyl-n-2-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-chlorofentanyl-n-2-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(82) ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 9828 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9852",
      "citation": "21 CFR 1308.11(b)(83)",
      "id": "ortho-fluoroacryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-acrylami",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-fluoroacryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-acrylami/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(83) ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) | 9852 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9846",
      "citation": "21 CFR 1308.11(b)(84)",
      "id": "ortho-fluorobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyra",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-fluorobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyra/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(84) ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) | 9846 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9816",
      "citation": "21 CFR 1308.11(b)(85)",
      "id": "ortho-fluorofentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide-a",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-fluorofentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide-a/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(85) ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl) | 9816 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9863",
      "citation": "21 CFR 1308.11(b)(86)",
      "id": "ortho-fluorofuranyl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-fluorofuranyl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(86) ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9863 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9853",
      "citation": "21 CFR 1308.11(b)(87)",
      "id": "ortho-fluoroisobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-iso",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-fluoroisobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-iso/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(87) ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9853 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9848",
      "citation": "21 CFR 1308.11(b)(88)",
      "id": "ortho-methyl-acetylfentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-acetami",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-methyl-acetylfentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-acetami/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(88) ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) | 9848 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9820",
      "citation": "21 CFR 1308.11(b)(90)",
      "id": "ortho-methyl-methoxyacetyl-fentanyl-2-methoxy-n-2-methylphenyl-n-1-phenethylpipe",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-methyl-methoxyacetyl-fentanyl-2-methoxy-n-2-methylphenyl-n-1-phenethylpipe/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(90) ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) | 9820 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9849",
      "citation": "21 CFR 1308.11(b)(89)",
      "id": "ortho-methylcyclopropyl-fentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-cy",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/ortho-methylcyclopropyl-fentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-cy/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(89) ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9849 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(76)",
      "id": "oxandrolone-17-methyl-17-hydroxy-2-oxa-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxandrolone-17-methyl-17-hydroxy-2-oxa-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(76) oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oxazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2835",
      "citation": "21 CFR 1308.14(c)(45)",
      "id": "oxazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(45) Oxazepam | 2835 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oxazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2839",
      "citation": "21 CFR 1308.14(c)(46)",
      "id": "oxazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(46) Oxazolam | 2839 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oxycodone",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9143",
      "citation": "21 CFR 1308.12(b)(1)(xiv)",
      "id": "oxycodone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxycodone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xiv) Oxycodone | 9143 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(77)",
      "id": "oxymesterone-17-methyl-4-17-dihydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxymesterone-17-methyl-4-17-dihydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(77) oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(78)",
      "id": "oxymetholone-17-methyl-2-hydroxymethylene-17-hydroxy-5-androstan-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxymetholone-17-methyl-2-hydroxymethylene-17-hydroxy-5-androstan-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(78) oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Oxymorphone",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9652",
      "citation": "21 CFR 1308.12(b)(1)(xv)",
      "id": "oxymorphone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/oxymorphone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xv) Oxymorphone | 9652 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9818",
      "citation": "21 CFR 1308.11(b)(92)",
      "id": "para-chlorofentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-chlorofentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(92) para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9818 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9826",
      "citation": "21 CFR 1308.11(b)(91)",
      "id": "para-chloroisobutyryl-fentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-isob",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-chloroisobutyryl-fentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-isob/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(91) para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9826 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9854",
      "citation": "21 CFR 1308.11(b)(95)",
      "id": "para-fluoro-furanyl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-fluoro-furanyl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(95) para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9854 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9870",
      "citation": "21 CFR 1308.11(b)(96)",
      "id": "para-fluoro-valeryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-pentan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-fluoro-valeryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-pentan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(96) para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) | 9870 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9823",
      "citation": "21 CFR 1308.11(b)(93)",
      "id": "para-fluorobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyram",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-fluorobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyram/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(93) para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9823 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9812",
      "citation": "21 CFR 1308.11(b)(94)",
      "id": "para-fluorofentanyl-n-4-fluorophenyl-n-1-2-phenylethyl-4-piperidinyl-propanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-fluorofentanyl-n-4-fluorophenyl-n-1-2-phenylethyl-4-piperidinyl-propanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(94) para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) | 9812 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9837",
      "citation": "21 CFR 1308.11(b)(97)",
      "id": "para-methoxybutyryl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-butyr",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-methoxybutyryl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-butyr/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(97) para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9837 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9859",
      "citation": "21 CFR 1308.11(b)(98)",
      "id": "para-methoxyfuranyl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-furan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-methoxyfuranyl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-furan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(98) para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide | 9859 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9865",
      "citation": "21 CFR 1308.11(b)(99)",
      "id": "para-methylcyclopropyl-fentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-cyc",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-methylcyclopropyl-fentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-cyc/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(99) para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9865 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9817",
      "citation": "21 CFR 1308.11(b)(100)",
      "id": "para-methylfentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-propionamide-al",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/para-methylfentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-propionamide-al/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(100) para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) | 9817 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Parahexyl",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7374",
      "citation": "21 CFR 1308.11(d)(25)",
      "id": "parahexyl",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/parahexyl/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(25) Parahexyl\u20147374",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Paraldehyde",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2585",
      "citation": "21 CFR 1308.14(c)(47)",
      "id": "paraldehyde",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/paraldehyde/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(47) Paraldehyde | 2585 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pemoline (including organometallic complexes and chelates thereof)",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1530",
      "citation": "21 CFR 1308.14(f)(8)",
      "id": "pemoline-including-organometallic-complexes-and-chelates-thereof",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pemoline-including-organometallic-complexes-and-chelates-thereof/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(8) Pemoline (including organometallic complexes and chelates thereof) | 1530 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pentazocine",
      "schedule": "Schedule IV",
      "category": "Other substances",
      "dea_code_number": "9709",
      "citation": "21 CFR 1308.14(g)(1)",
      "id": "pentazocine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pentazocine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Pentazocine | 9709 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pentobarbital",
      "schedule": "Schedule II",
      "category": "Depressants",
      "dea_code_number": "2270",
      "citation": "21 CFR 1308.12(e)(3)",
      "id": "pentobarbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pentobarbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Pentobarbital | 2270 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pentobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2271",
      "scope_qualifier": "Any compound, mixture or preparation containing",
      "citation": "21 CFR 1308.13(c)(1)(iii)",
      "id": "pentobarbital-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pentobarbital-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pentobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2271",
      "scope_qualifier": "Any suppository dosage form containing",
      "citation": "21 CFR 1308.13(c)(2)(iii)",
      "id": "pentobarbital-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pentobarbital-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9663",
      "citation": "21 CFR 1308.11(b)(101)",
      "id": "pepap-1-2-phenylethyl-4-phenyl-4-acetoxypiperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pepap-1-2-phenylethyl-4-phenyl-4-acetoxypiperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(101) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine) | 9663 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Perampanel, and its salts, isomers, and salts of isomers",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2261",
      "citation": "21 CFR 1308.13(c)(11)",
      "id": "perampanel-and-its-salts-isomers-and-salts-of-isomers",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/perampanel-and-its-salts-isomers-and-salts-of-isomers/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Perampanel, and its salts, isomers, and salts of isomers | 2261 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9232",
      "citation": "21 CFR 1308.12(c)(20)",
      "id": "pethidine-intermediate-a-4-cyano-1-methyl-4-phenylpiperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pethidine-intermediate-a-4-cyano-1-methyl-4-phenylpiperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine | 9232 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9233",
      "citation": "21 CFR 1308.12(c)(21)",
      "id": "pethidine-intermediate-b-ethyl-4-phenylpiperidine-4-carboxylate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pethidine-intermediate-b-ethyl-4-phenylpiperidine-4-carboxylate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate | 9233 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9234",
      "citation": "21 CFR 1308.12(c)(22)",
      "id": "pethidine-intermediate-c-1-methyl-4-phenylpiperidine-4-carboxylic-acid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pethidine-intermediate-c-1-methyl-4-phenylpiperidine-4-carboxylic-acid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid | 9234 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pethidine (meperidine)",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9230",
      "citation": "21 CFR 1308.12(c)(19)",
      "id": "pethidine-meperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pethidine-meperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(19) Pethidine (meperidine) | 9230 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Petrichloral",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2591",
      "citation": "21 CFR 1308.14(c)(48)",
      "id": "petrichloral",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/petrichloral/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(48) Petrichloral | 2591 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Peyote",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7415",
      "citation": "21 CFR 1308.11(d)(26)",
      "id": "peyote",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/peyote/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(26) Peyote | 7415 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenadoxone",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9637",
      "citation": "21 CFR 1308.11(b)(102)",
      "id": "phenadoxone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenadoxone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(102) Phenadoxone | 9637 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenampromide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9638",
      "citation": "21 CFR 1308.11(b)(103)",
      "id": "phenampromide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenampromide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(103) Phenampromide | 9638 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenazocine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9715",
      "citation": "21 CFR 1308.12(c)(23)",
      "id": "phenazocine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenazocine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) Phenazocine | 9715 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phencyclidine",
      "schedule": "Schedule II",
      "category": "Depressants",
      "dea_code_number": "7471",
      "citation": "21 CFR 1308.12(e)(4)",
      "id": "phencyclidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phencyclidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(4) Phencyclidine | 7471 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phendimetrazine",
      "schedule": "Schedule III",
      "category": "Stimulants",
      "dea_code_number": "1615",
      "citation": "21 CFR 1308.13(b)(5)",
      "id": "phendimetrazine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phendimetrazine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Phendimetrazine | 1615 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenmetrazine and its salts",
      "schedule": "Schedule II",
      "category": "Stimulants",
      "dea_code_number": "1631",
      "citation": "21 CFR 1308.12(d)(3)",
      "id": "phenmetrazine-and-its-salts",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenmetrazine-and-its-salts/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(3) Phenmetrazine and its salts | 1631 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenobarbital",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2285",
      "citation": "21 CFR 1308.14(c)(49)",
      "id": "phenobarbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenobarbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(49) Phenobarbital | 2285 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenomorphan",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9647",
      "citation": "21 CFR 1308.11(b)(104)",
      "id": "phenomorphan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenomorphan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(104) Phenomorphan | 9647 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenoperidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9641",
      "citation": "21 CFR 1308.11(b)(105)",
      "id": "phenoperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenoperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(105) Phenoperidine | 9641 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phentermine",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1640",
      "citation": "21 CFR 1308.14(f)(9)",
      "id": "phentermine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phentermine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(9) Phentermine | 1640 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9841",
      "citation": "21 CFR 1308.11(b)(106)",
      "id": "phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbenzamide-also-known-as-benz",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbenzamide-also-known-as-benz/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(106) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) | 9841 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Phenylacetone",
      "schedule": "Schedule II",
      "category": "Immediate precursors",
      "dea_code_number": "8501",
      "citation": "21 CFR 1308.12(g)(1)(i)",
      "id": "phenylacetone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/phenylacetone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(i) Phenylacetone | 8501 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pholcodine",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9314",
      "citation": "21 CFR 1308.11(c)(22)",
      "id": "pholcodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pholcodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(22) Pholcodine | 9314 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Piminodine",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9730",
      "citation": "21 CFR 1308.12(c)(24)",
      "id": "piminodine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/piminodine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(24) Piminodine | 9730 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pinazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2883",
      "citation": "21 CFR 1308.14(c)(50)",
      "id": "pinazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pinazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(50) Pinazepam | 2883 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pipradrol",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1750",
      "citation": "21 CFR 1308.14(f)(10)",
      "id": "pipradrol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pipradrol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(10) Pipradrol | 1750 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Piritramide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9642",
      "citation": "21 CFR 1308.11(b)(107)",
      "id": "piritramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/piritramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(107) Piritramide | 9642 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Powdered opium",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9639",
      "citation": "21 CFR 1308.12(b)(1)(xvi)",
      "id": "powdered-opium",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/powdered-opium/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xvi) Powdered opium | 9639 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Prazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2764",
      "citation": "21 CFR 1308.14(c)(51)",
      "id": "prazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/prazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(51) Prazepam | 2764 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]",
      "schedule": "Schedule V",
      "category": "Depressants",
      "dea_code_number": "2782",
      "citation": "21 CFR 1308.15(e)(7)",
      "id": "pregabalin-s-3-aminomethyl-5-methylhexanoic-acid",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pregabalin-s-3-aminomethyl-5-methylhexanoic-acid/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(7) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] | 2782 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Proheptazine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9643",
      "citation": "21 CFR 1308.11(b)(108)",
      "id": "proheptazine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/proheptazine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(108) Proheptazine | 9643 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Properidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9644",
      "citation": "21 CFR 1308.11(b)(109)",
      "id": "properidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/properidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(109) Properidine | 9644 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Propiram",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9649",
      "citation": "21 CFR 1308.11(b)(110)",
      "id": "propiram",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/propiram/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(110) Propiram | 9649 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(79)",
      "id": "prostanozol-17-hydroxy-5-androstano-3-2-c-pyrazole-or-3-2-c-pyrazole-5-androstan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/prostanozol-17-hydroxy-5-androstano-3-2-c-pyrazole-or-3-2-c-pyrazole-5-androstan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(79) prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Psilocybin",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7437",
      "citation": "21 CFR 1308.11(d)(29)",
      "id": "psilocybin",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/psilocybin/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(29) Psilocybin | 7437 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Psilocyn",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7438",
      "citation": "21 CFR 1308.11(d)(30)",
      "id": "psilocyn",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/psilocyn/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) Psilocyn | 7438 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pyrovalerone",
      "schedule": "Schedule V",
      "category": "Stimulants",
      "dea_code_number": "1485",
      "citation": "21 CFR 1308.15(d)(1)",
      "id": "pyrovalerone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pyrovalerone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Pyrovalerone | 1485. |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Pyrrolidine analog of phencyclidine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7458",
      "citation": "21 CFR 1308.11(d)(33)",
      "id": "pyrrolidine-analog-of-phencyclidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/pyrrolidine-analog-of-phencyclidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(33) Pyrrolidine analog of phencyclidine | 7458 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Quazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2881",
      "citation": "21 CFR 1308.14(c)(52)",
      "id": "quazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/quazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(52) Quazepam | 2881 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7225",
      "citation": "21 CFR 1308.11(d)(52)",
      "id": "quinolin-8-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-5-fluoro-pb-22-5f-pb-22",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/quinolin-8-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-5-fluoro-pb-22-5f-pb-22/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(52) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) | (7225) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC)",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7222",
      "citation": "21 CFR 1308.11(d)(51)",
      "id": "quinolin-8-yl-1-pentyl-1h-indole-3-carboxylate-pb-22-qupic",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/quinolin-8-yl-1-pentyl-1h-indole-3-carboxylate-pb-22-qupic/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(51) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) | (7222) |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Racemethorphan",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9732",
      "citation": "21 CFR 1308.12(c)(25)",
      "id": "racemethorphan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/racemethorphan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(25) Racemethorphan | 9732 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Racemoramide",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9645",
      "citation": "21 CFR 1308.11(b)(112)",
      "id": "racemoramide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/racemoramide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(112) Racemoramide | 9645 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Racemorphan",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9733",
      "citation": "21 CFR 1308.12(c)(26)",
      "id": "racemorphan",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/racemorphan/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(26) Racemorphan | 9733 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Raw opium",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9600",
      "citation": "21 CFR 1308.12(b)(1)(xvii)",
      "id": "raw-opium",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/raw-opium/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xvii) Raw opium | 9600 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Remifentanil",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9739",
      "citation": "21 CFR 1308.12(c)(27)",
      "id": "remifentanil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/remifentanil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(27) Remifentanil | 9739 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Remimazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2846",
      "citation": "21 CFR 1308.14(c)(53)",
      "id": "remimazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/remimazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(53) Remimazolam | 2846 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Secobarbital",
      "schedule": "Schedule II",
      "category": "Depressants",
      "dea_code_number": "2315",
      "citation": "21 CFR 1308.12(e)(5)",
      "id": "secobarbital",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/secobarbital/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(5) Secobarbital | 2315 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Secobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2316",
      "scope_qualifier": "Any compound, mixture or preparation containing",
      "citation": "21 CFR 1308.13(c)(1)(ii)",
      "id": "secobarbital-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/secobarbital-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Secobarbital",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2316",
      "scope_qualifier": "Any suppository dosage form containing",
      "citation": "21 CFR 1308.13(c)(2)(ii)",
      "id": "secobarbital-3",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/secobarbital-3/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "scope_qualifier",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Serdexmethylphenidate",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1729",
      "citation": "21 CFR 1308.14(f)(11)",
      "id": "serdexmethylphenidate",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/serdexmethylphenidate/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(11) Serdexmethylphenidate | 1729 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Sibutramine",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1675",
      "citation": "21 CFR 1308.14(f)(12)",
      "id": "sibutramine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/sibutramine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) Sibutramine | 1675 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester))",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1650",
      "citation": "21 CFR 1308.14(f)(13)",
      "id": "solriamfetol-2-amino-3-phenylpropyl-carbamate-benzenepropanol-beta-amino-carbama",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/solriamfetol-2-amino-3-phenylpropyl-carbamate-benzenepropanol-beta-amino-carbama/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) | 1650 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "SPA ((-)-1-dimethylamino- 1,2-diphenylethane)",
      "schedule": "Schedule IV",
      "category": "Stimulants",
      "dea_code_number": "1635",
      "citation": "21 CFR 1308.14(f)(14)",
      "id": "spa-1-dimethylamino-1-2-diphenylethane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/spa-1-dimethylamino-1-2-diphenylethane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) SPA ((-)-1-dimethylamino- 1,2-diphenylethane) | 1635 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(81)",
      "id": "stanozolol-17-methyl-17-hydroxy-5-androst-2-eno-3-2-c-pyrazole",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/stanozolol-17-methyl-17-hydroxy-5-androst-2-eno-3-2-c-pyrazole/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(81) stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(82)",
      "id": "stenbolone-17-hydroxy-2-methyl-5-androst-1-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/stenbolone-17-hydroxy-2-methyl-5-androst-1-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(82) stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Sufentanil",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9740",
      "citation": "21 CFR 1308.12(c)(28)",
      "id": "sufentanil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/sufentanil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(28) Sufentanil | 9740 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Sulfondiethylmethane",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2600",
      "citation": "21 CFR 1308.13(c)(12)",
      "id": "sulfondiethylmethane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/sulfondiethylmethane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(12) Sulfondiethylmethane | 2600 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Sulfonethylmethane",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2605",
      "citation": "21 CFR 1308.13(c)(13)",
      "id": "sulfonethylmethane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/sulfonethylmethane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(13) Sulfonethylmethane | 2605 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Sulfonmethane",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "2610",
      "citation": "21 CFR 1308.13(c)(14)",
      "id": "sulfonmethane",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/sulfonmethane/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(14) Sulfonmethane | 2610 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Suvorexant",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2223",
      "citation": "21 CFR 1308.14(c)(54)",
      "id": "suvorexant",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/suvorexant/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(54) Suvorexant | 2223 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tapentadol",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9780",
      "citation": "21 CFR 1308.12(c)(29)",
      "id": "tapentadol",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tapentadol/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(29) Tapentadol | 9780 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Temazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2925",
      "citation": "21 CFR 1308.14(c)(55)",
      "id": "temazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/temazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(55) Temazepam | 2925 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(83)",
      "id": "testolactone-13-hydroxy-3-oxo-13-17-secoandrosta-1-4-dien-17-oic-acid-lactone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/testolactone-13-hydroxy-3-oxo-13-17-secoandrosta-1-4-dien-17-oic-acid-lactone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(83) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "testosterone (17\u03b2-hydroxyandrost-4-en-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(84)",
      "id": "testosterone-17-hydroxyandrost-4-en-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/testosterone-17-hydroxyandrost-4-en-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(84) testosterone (17\u03b2-hydroxyandrost-4-en-3-one);",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tetrahydrocannabinols",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7370",
      "citation": "21 CFR 1308.11(d)(31)",
      "id": "tetrahydrocannabinols",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tetrahydrocannabinols/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(31) Tetrahydrocannabinols | 7370 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9843",
      "citation": "21 CFR 1308.11(b)(113)",
      "id": "tetrahydrofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenyltetrahydrofuran-2",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tetrahydrofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenyltetrahydrofuran-2/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(113) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) | 9843 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(85)",
      "id": "tetrahydrogestrinone-13-17-diethyl-17-hydroxygon-4-9-11-trien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tetrahydrogestrinone-13-17-diethyl-17-hydroxygon-4-9-11-trien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(85) tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one); and",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9869",
      "citation": "21 CFR 1308.11(b)(114)",
      "id": "tetrahydrothiofuranyl-fentanyl-also-known-as-tetrahydrothiophene-fentanyl-n-1-ph",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tetrahydrothiofuranyl-fentanyl-also-known-as-tetrahydrothiophene-fentanyl-n-1-ph/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(114) tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) | 9869 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tetrazepam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2886",
      "citation": "21 CFR 1308.14(c)(56)",
      "id": "tetrazepam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tetrazepam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(56) Tetrazepam | 2886 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thebacon",
      "schedule": "Schedule I",
      "category": "Opium derivatives",
      "dea_code_number": "9315",
      "citation": "21 CFR 1308.11(c)(23)",
      "id": "thebacon",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thebacon/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(23) Thebacon | 9315 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thebaine",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9333",
      "citation": "21 CFR 1308.12(b)(1)(xviii)",
      "id": "thebaine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thebaine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xviii) Thebaine | 9333 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thiafentanil",
      "schedule": "Schedule II",
      "category": "Opiates",
      "dea_code_number": "9729",
      "citation": "21 CFR 1308.12(c)(30)",
      "id": "thiafentanil",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thiafentanil/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(30) Thiafentanil | 9729 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9835",
      "citation": "21 CFR 1308.11(b)(115)",
      "id": "thiofentanyl-n-phenyl-n-1-2-thienyl-ethyl-4-piperidinyl-propanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thiofentanyl-n-phenyl-n-1-2-thienyl-ethyl-4-piperidinyl-propanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(115) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide) | 9835 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9839",
      "citation": "21 CFR 1308.11(b)(116)",
      "id": "thiofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylthiophene-2-carboxamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thiofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylthiophene-2-carboxamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(116) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) | 9839 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Thiophene analog of phencyclidine",
      "schedule": "Schedule I",
      "category": "Hallucinogenic substances",
      "dea_code_number": "7470",
      "citation": "21 CFR 1308.11(d)(34)",
      "id": "thiophene-analog-of-phencyclidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/thiophene-analog-of-phencyclidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(34) Thiophene analog of phencyclidine | 7470 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances",
      "schedule": "Schedule III",
      "category": "Stimulants",
      "dea_code_number": "1405",
      "citation": "21 CFR 1308.13(b)(1)",
      "id": "those-compounds-mixtures-or-preparations-in-dosage-unit-form-containing-any-stim",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/those-compounds-mixtures-or-preparations-in-dosage-unit-form-containing-any-stim/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances | 1405 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tiletamine and zolazepam or any salt thereof",
      "schedule": "Schedule III",
      "category": "Depressants",
      "dea_code_number": "7295",
      "citation": "21 CFR 1308.13(c)(15)",
      "id": "tiletamine-and-zolazepam-or-any-salt-thereof",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tiletamine-and-zolazepam-or-any-salt-thereof/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(15) Tiletamine and zolazepam or any salt thereof | 7295 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tilidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9750",
      "citation": "21 CFR 1308.11(b)(117)",
      "id": "tilidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tilidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(117) Tilidine | 9750 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Tincture of opium",
      "schedule": "Schedule II",
      "category": "Substances, vegetable origin or chemical synthesis",
      "dea_code_number": "9630",
      "citation": "21 CFR 1308.12(b)(1)(xix)",
      "id": "tincture-of-opium",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/tincture-of-opium/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(xix) Tincture of opium | 9630 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one)",
      "schedule": "Schedule III",
      "category": "Anabolic steroids",
      "citation": "21 CFR 1308.13(f)(86)",
      "id": "trenbolone-17-hydroxyestr-4-9-11-trien-3-one",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/trenbolone-17-hydroxyestr-4-9-11-trien-3-one/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(86) trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one).",
      "verified_fields": [
        "category",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Triazolam",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2887",
      "citation": "21 CFR 1308.14(c)(57)",
      "id": "triazolam",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/triazolam/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(57) Triazolam | 2887 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Trimeperidine",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9646",
      "citation": "21 CFR 1308.11(b)(118)",
      "id": "trimeperidine",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/trimeperidine/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(118) Trimeperidine | 9646 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9547",
      "citation": "21 CFR 1308.11(b)(119)",
      "id": "u-47700-3-4-dichloro-n-2-dimethylamino-cyclohexyl-n-methylbenzamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/u-47700-3-4-dichloro-n-2-dimethylamino-cyclohexyl-n-methylbenzamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(119) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9840",
      "citation": "21 CFR 1308.11(b)(120)",
      "id": "valeryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylpentanamide",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/valeryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylpentanamide/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(120) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) | 9840 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Zaleplon",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2781",
      "citation": "21 CFR 1308.14(c)(58)",
      "id": "zaleplon",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/zaleplon/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(58) Zaleplon | 2781 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)",
      "schedule": "Schedule I",
      "category": "Opiates",
      "dea_code_number": "9873",
      "citation": "21 CFR 1308.11(b)(121)",
      "id": "zipeprol-1-methoxy-3-4-2-methoxy-2-phenylethyl-piperazin-1-yl-1-phenylpropan-2-o",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/zipeprol-1-methoxy-3-4-2-methoxy-2-phenylethyl-piperazin-1-yl-1-phenylpropan-2-o/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(121) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) | 9873 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Zolpidem",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2783",
      "citation": "21 CFR 1308.14(c)(59)",
      "id": "zolpidem",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/zolpidem/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(59) Zolpidem | 2783 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Zopiclone",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2784",
      "citation": "21 CFR 1308.14(c)(60)",
      "id": "zopiclone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/zopiclone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(60) Zopiclone | 2784 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    },
    {
      "substance_name": "Zuranolone",
      "schedule": "Schedule IV",
      "category": "Depressants",
      "dea_code_number": "2420",
      "citation": "21 CFR 1308.14(c)(61)",
      "id": "zuranolone",
      "url": "https://referencesource.org/dea-controlled-substance-schedule-by-drug/zuranolone/",
      "source": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308",
      "source_quote": "(61) Zuranolone | 2420 |",
      "verified_fields": [
        "category",
        "dea_code_number",
        "schedule",
        "substance_name"
      ],
      "derived_fields": [
        "citation"
      ]
    }
  ]
}